<?xml version="1.0" encoding="utf-8"?>
<xbrl
  xmlns="http://www.xbrl.org/2003/instance"
  xmlns:ccxi="http://churchillcapital9.com/20260331"
  xmlns:dei="http://xbrl.sec.gov/dei/2026"
  xmlns:ecd="http://xbrl.sec.gov/ecd/2026"
  xmlns:iso4217="http://www.xbrl.org/2003/iso4217"
  xmlns:link="http://www.xbrl.org/2003/linkbase"
  xmlns:srt="http://fasb.org/srt/2026"
  xmlns:us-gaap="http://fasb.org/us-gaap/2026"
  xmlns:xbrldi="http://xbrl.org/2006/xbrldi"
  xmlns:xlink="http://www.w3.org/1999/xlink"
  xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
    <link:schemaRef xlink:href="ccxi-20260331.xsd" xlink:type="simple"/>
    <context id="cref_598338636">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002074973</identifier>
        </entity>
        <period>
            <startDate>2026-01-01</startDate>
            <endDate>2026-03-31</endDate>
        </period>
    </context>
    <context id="cref_1046053354">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002074973</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2026-04-16</instant>
        </period>
    </context>
    <context id="cref_2146114570">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002074973</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USTreasurySecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-12-31</instant>
        </period>
    </context>
    <context id="cref_247669961">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002074973</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USTreasurySecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-06-04</startDate>
            <endDate>2025-12-31</endDate>
        </period>
    </context>
    <context id="cref_368141196">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002074973</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-12-31</instant>
        </period>
    </context>
    <context id="cref_316440687">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002074973</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-12-31</instant>
        </period>
    </context>
    <context id="cref_1953307244">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002074973</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USTreasurySecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2026-03-31</instant>
        </period>
    </context>
    <context id="cref_1769502998">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002074973</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USTreasurySecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2026-01-01</startDate>
            <endDate>2026-03-31</endDate>
        </period>
    </context>
    <context id="cref_1340897797">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002074973</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2026-03-31</instant>
        </period>
    </context>
    <context id="cref_934243015">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002074973</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2026-03-31</instant>
        </period>
    </context>
    <context id="cref_294760605">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002074973</identifier>
        </entity>
        <period>
            <instant>2025-12-31</instant>
        </period>
    </context>
    <context id="cref_886637457">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002074973</identifier>
        </entity>
        <period>
            <instant>2026-03-31</instant>
        </period>
    </context>
    <context id="cref_1083338889">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002074973</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassAMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2026-01-01</startDate>
            <endDate>2026-03-31</endDate>
        </period>
    </context>
    <context id="cref_1965182610">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002074973</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2026-01-01</startDate>
            <endDate>2026-03-31</endDate>
        </period>
    </context>
    <context id="cref_40809227">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002074973</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2026-01-01</startDate>
            <endDate>2026-03-31</endDate>
        </period>
    </context>
    <context id="cref_123589252">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002074973</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">ccxi:WarrantsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassAMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2026-03-31</instant>
        </period>
    </context>
    <context id="cref_402311162">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002074973</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">ccxi:WarrantsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2026-01-01</startDate>
            <endDate>2026-03-31</endDate>
        </period>
    </context>
    <context id="cref_789349549">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002074973</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">ccxi:WarrantsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2026-03-31</instant>
        </period>
    </context>
    <context id="cref_438597182">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002074973</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassAMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2026-03-31</instant>
        </period>
    </context>
    <context id="cref_1685859283">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002074973</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">us-gaap:SeriesOfIndividuallyImmaterialBusinessAcquisitionsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassAMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2026-03-31</instant>
        </period>
    </context>
    <context id="cref_1273373180">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002074973</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">ccxi:PrivatePlacementWarrantsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-12-31</instant>
        </period>
    </context>
    <context id="cref_344168120">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002074973</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">ccxi:PublicWarrantMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2026-03-31</instant>
        </period>
    </context>
    <context id="cref_1880167681">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002074973</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassBMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:IPOMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2026-03-31</instant>
        </period>
    </context>
    <context id="cref_51160283">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002074973</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassBMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2026-03-31</instant>
        </period>
    </context>
    <context id="cref_107229769">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002074973</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassBMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-12-31</instant>
        </period>
    </context>
    <context id="cref_165471328">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002074973</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassAMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-12-31</instant>
        </period>
    </context>
    <context id="cref_2103209578">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002074973</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2026-03-25</startDate>
            <endDate>2026-03-25</endDate>
        </period>
    </context>
    <context id="cref_1061322807">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002074973</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2026-03-25</startDate>
            <endDate>2026-03-25</endDate>
        </period>
    </context>
    <context id="cref_440113746">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002074973</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:IPOMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">ccxi:UnderwritingAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2026-01-01</startDate>
            <endDate>2026-03-31</endDate>
        </period>
    </context>
    <context id="cref_543469871">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002074973</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">ccxi:UnderwritingAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2026-01-01</startDate>
            <endDate>2026-03-31</endDate>
        </period>
    </context>
    <context id="cref_1622821628">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002074973</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">ccxi:UnderwritingAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2026-03-31</instant>
        </period>
    </context>
    <context id="cref_734378815">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002074973</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:IPOMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2026-01-01</startDate>
            <endDate>2026-03-31</endDate>
        </period>
    </context>
    <context id="cref_1206905538">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002074973</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:OverAllotmentOptionMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">ccxi:UnderwritingAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-12-18</instant>
        </period>
    </context>
    <context id="cref_1117640675">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002074973</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:OverAllotmentOptionMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">ccxi:UnderwritingAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-12-18</startDate>
            <endDate>2025-12-18</endDate>
        </period>
    </context>
    <context id="cref_154218680">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002074973</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:OverAllotmentOptionMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">ccxi:UnderwritingAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2026-01-01</startDate>
            <endDate>2026-03-31</endDate>
        </period>
    </context>
    <context id="cref_176815138">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002074973</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:PrivatePlacementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2026-03-31</instant>
        </period>
    </context>
    <context id="cref_811510108">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002074973</identifier>
        </entity>
        <period>
            <startDate>2026-03-17</startDate>
            <endDate>2026-03-17</endDate>
        </period>
    </context>
    <context id="cref_1030443559">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002074973</identifier>
        </entity>
        <period>
            <startDate>2025-12-17</startDate>
            <endDate>2025-12-17</endDate>
        </period>
    </context>
    <context id="cref_1044380028">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002074973</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">us-gaap:RelatedPartyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2026-01-01</startDate>
            <endDate>2026-03-31</endDate>
        </period>
    </context>
    <context id="cref_1043500938">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002074973</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">ccxi:SponsorMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-06-04</startDate>
            <endDate>2025-06-04</endDate>
        </period>
    </context>
    <context id="cref_1429513406">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002074973</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">ccxi:SponsorMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">ccxi:FounderSharesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-03-31</endDate>
        </period>
    </context>
    <context id="cref_415477080">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002074973</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">ccxi:SponsorMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-03-31</endDate>
        </period>
    </context>
    <context id="cref_1721169663">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002074973</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassBMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">ccxi:FounderSharesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-11-30</instant>
        </period>
    </context>
    <context id="cref_1102980629">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002074973</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">ccxi:SponsorMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-11-01</startDate>
            <endDate>2025-11-30</endDate>
        </period>
    </context>
    <context id="cref_2127870742">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002074973</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">ccxi:FounderSharesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-06-04</instant>
        </period>
    </context>
    <context id="cref_1716086651">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002074973</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassBMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">ccxi:FounderSharesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-06-04</startDate>
            <endDate>2025-06-04</endDate>
        </period>
    </context>
    <context id="cref_2056961191">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002074973</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassBMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">ccxi:FounderSharesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-06-04</instant>
        </period>
    </context>
    <context id="cref_1055378908">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002074973</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">ccxi:PrivatePlacementWarrantMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2026-01-01</startDate>
            <endDate>2026-03-31</endDate>
        </period>
    </context>
    <context id="cref_1928010055">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002074973</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">ccxi:PrivatePlacementWarrantMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassAMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2026-03-31</instant>
        </period>
    </context>
    <context id="cref_2094027022">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002074973</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">ccxi:PrivatePlacementWarrantMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:IPOMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2026-01-01</startDate>
            <endDate>2026-03-31</endDate>
        </period>
    </context>
    <context id="cref_769804437">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002074973</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">ccxi:PublicWarrantMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassAMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2026-03-31</instant>
        </period>
    </context>
    <context id="cref_1648036551">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002074973</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:IPOMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2026-03-31</instant>
        </period>
    </context>
    <context id="cref_92946457">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002074973</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">ccxi:PrivateWarrantMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-12-31</instant>
        </period>
    </context>
    <context id="cref_1211178341">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002074973</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">ccxi:ClassAOrdinarySharesSubjectToPossibleRedemptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2026-03-31</instant>
        </period>
    </context>
    <context id="cref_2147129175">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002074973</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">ccxi:ClassAOrdinarySharesSubjectToPossibleRedemptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2026-01-01</startDate>
            <endDate>2026-03-31</endDate>
        </period>
    </context>
    <context id="cref_1457352392">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002074973</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">ccxi:ClassAOrdinarySharesSubjectToPossibleRedemptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-12-31</instant>
        </period>
    </context>
    <context id="cref_1351018194">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002074973</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">ccxi:ClassAOrdinarySharesSubjectToPossibleRedemptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-06-04</startDate>
            <endDate>2025-12-31</endDate>
        </period>
    </context>
    <context id="cref_1326103014">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002074973</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassBMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2026-01-01</startDate>
            <endDate>2026-03-31</endDate>
        </period>
    </context>
    <context id="cref_1940557082">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002074973</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">us-gaap:WarrantMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassAMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2026-01-01</startDate>
            <endDate>2026-03-31</endDate>
        </period>
    </context>
    <context id="cref_964743498">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002074973</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">us-gaap:SeriesOfIndividuallyImmaterialBusinessAcquisitionsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2026-03-31</instant>
        </period>
    </context>
    <context id="cref_528632504">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002074973</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:IPOMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-12-18</startDate>
            <endDate>2025-12-18</endDate>
        </period>
    </context>
    <context id="cref_1387385282">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002074973</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:IPOMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-12-18</instant>
        </period>
    </context>
    <context id="cref_1545553815">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002074973</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">ccxi:PublicWarrantMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassAMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-12-18</instant>
        </period>
    </context>
    <context id="cref_1625903985">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002074973</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">ccxi:PrivatePlacementWarrantsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-12-18</instant>
        </period>
    </context>
    <context id="cref_2002993252">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002074973</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:PrivatePlacementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-12-18</instant>
        </period>
    </context>
    <context id="cref_508538335">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002074973</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">ccxi:PrivatePlacementWarrantsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-12-18</startDate>
            <endDate>2025-12-18</endDate>
        </period>
    </context>
    <context id="cref_1528584890">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002074973</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">ccxi:PrivatePlacementWarrantsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">ccxi:SponsorMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-12-18</instant>
        </period>
    </context>
    <context id="cref_882498764">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002074973</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">ccxi:PrivatePlacementWarrantsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:IPOMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-12-18</startDate>
            <endDate>2025-12-18</endDate>
        </period>
    </context>
    <context id="cref_229853459">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002074973</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">ccxi:PublicWarrantMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-12-18</instant>
        </period>
    </context>
    <context id="cref_442909652">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002074973</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">ccxi:SponsorMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassAMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:IPOMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-12-18</instant>
        </period>
    </context>
    <context id="cref_675931165">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002074973</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">ccxi:SponsorMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:IPOMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-12-18</startDate>
            <endDate>2025-12-18</endDate>
        </period>
    </context>
    <context id="cref_426171136">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002074973</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">ccxi:SponsorMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:OverAllotmentOptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-12-18</instant>
        </period>
    </context>
    <context id="cref_1439813851">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002074973</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">ccxi:SponsorMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:OverAllotmentOptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-12-18</startDate>
            <endDate>2025-12-18</endDate>
        </period>
    </context>
    <context id="cref_360949448">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002074973</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassAMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:IPOMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-12-18</startDate>
            <endDate>2025-12-18</endDate>
        </period>
    </context>
    <context id="cref_211675031">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002074973</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2026-03-31</instant>
        </period>
    </context>
    <context id="cref_233192784">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002074973</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassBMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2026-03-31</instant>
        </period>
    </context>
    <context id="cref_235862386">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002074973</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassAMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2026-03-31</instant>
        </period>
    </context>
    <context id="cref_993580423">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002074973</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2026-01-01</startDate>
            <endDate>2026-03-31</endDate>
        </period>
    </context>
    <context id="cref_1910314510">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002074973</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-12-31</instant>
        </period>
    </context>
    <context id="cref_1163785961">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002074973</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassBMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-12-31</instant>
        </period>
    </context>
    <context id="cref_2052403743">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002074973</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassAMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-12-31</instant>
        </period>
    </context>
    <context id="cref_1299616844">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002074973</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassBMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2026-05-13</instant>
        </period>
    </context>
    <context id="cref_1543236063">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002074973</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassAMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2026-05-13</instant>
        </period>
    </context>
    <context id="cref_1581394983">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002074973</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">ccxi:WarrantsEachWholeWarrantExercisableForOneClassAOrdinaryShareAtAnExercisePriceOf1150PerShareMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2026-01-01</startDate>
            <endDate>2026-03-31</endDate>
        </period>
    </context>
    <context id="cref_999510150">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002074973</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">ccxi:ClassAOrdinarySharesParValue00001PerShareMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2026-01-01</startDate>
            <endDate>2026-03-31</endDate>
        </period>
    </context>
    <context id="cref_1297356631">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002074973</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">ccxi:UnitsEachConsistingOfOneClassAOrdinaryShareAndOnetenthOfOneRedeemableWarrantMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2026-01-01</startDate>
            <endDate>2026-03-31</endDate>
        </period>
    </context>
    <context id="cref_2139298633">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002074973</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2026-03-31</instant>
        </period>
    </context>
    <context id="cref_492134705">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002074973</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassAMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2026-01-01</startDate>
            <endDate>2026-03-31</endDate>
        </period>
    </context>
    <context id="cref_2088266185">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002074973</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassBMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2026-01-01</startDate>
            <endDate>2026-03-31</endDate>
        </period>
    </context>
    <context id="cref_1070095916">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002074973</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2026-01-01</startDate>
            <endDate>2026-03-31</endDate>
        </period>
    </context>
    <context id="cref_2027863549">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002074973</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">ccxi:DirectorAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2026-01-01</startDate>
            <endDate>2026-03-31</endDate>
        </period>
    </context>
    <context id="cref_671122245">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002074973</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-12-31</instant>
        </period>
    </context>
    <context id="cref_1200964243">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002074973</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">srt:ChiefExecutiveOfficerMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2026-01-01</startDate>
            <endDate>2026-03-31</endDate>
        </period>
    </context>
    <context id="cref_715216225">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002074973</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">srt:ChiefFinancialOfficerMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2026-01-01</startDate>
            <endDate>2026-03-31</endDate>
        </period>
    </context>
    <unit id="uref_1046053354">
        <measure>iso4217:USD</measure>
    </unit>
    <unit id="uref_322019321">
        <measure>ccxi:Segment</measure>
    </unit>
    <unit id="uref_123589252">
        <divide>
            <unitNumerator>
                <measure>iso4217:USD</measure>
            </unitNumerator>
            <unitDenominator>
                <measure>shares</measure>
            </unitDenominator>
        </divide>
    </unit>
    <unit id="uref_1880167681">
        <measure>shares</measure>
    </unit>
    <unit id="uref_2103209578">
        <measure>pure</measure>
    </unit>
    <us-gaap:AdditionalPaidInCapital
      contextRef="cref_294760605"
      id="fc_1064371104"
      unitRef="uref_1046053354"
      xsi:nil="true"/>
    <us-gaap:PreferredStockSharesIssued
      contextRef="cref_886637457"
      id="fc_1658635913"
      unitRef="uref_1880167681"
      xsi:nil="true"/>
    <us-gaap:PreferredStockSharesOutstanding
      contextRef="cref_886637457"
      id="fc_816577760"
      unitRef="uref_1880167681"
      xsi:nil="true"/>
    <us-gaap:StockholdersEquity
      contextRef="cref_2139298633"
      id="fc_2139298633"
      unitRef="uref_1046053354"
      xsi:nil="true"/>
    <us-gaap:TemporaryEquityAccretionToRedemptionValue
      contextRef="cref_492134705"
      id="fc_492134705"
      unitRef="uref_1046053354"
      xsi:nil="true"/>
    <us-gaap:TemporaryEquityAccretionToRedemptionValue
      contextRef="cref_2088266185"
      id="fc_2088266185"
      unitRef="uref_1046053354"
      xsi:nil="true"/>
    <us-gaap:TemporaryEquityAccretionToRedemptionValue
      contextRef="cref_1070095916"
      id="fc_1070095916"
      unitRef="uref_1046053354"
      xsi:nil="true"/>
    <us-gaap:CommitmentsAndContingencies
      contextRef="cref_886637457"
      id="fc_2095382012"
      unitRef="uref_1046053354"
      xsi:nil="true"/>
    <us-gaap:PreferredStockValue
      contextRef="cref_886637457"
      id="fc_1256255521"
      unitRef="uref_1046053354"
      xsi:nil="true"/>
    <us-gaap:AdditionalPaidInCapital
      contextRef="cref_886637457"
      id="fc_1048259179"
      unitRef="uref_1046053354"
      xsi:nil="true"/>
    <us-gaap:PaymentsForFees
      contextRef="cref_2027863549"
      id="fc_2027863549"
      unitRef="uref_1046053354"
      xsi:nil="true"/>
    <ccxi:WorkingCapitalLoan
      contextRef="cref_886637457"
      id="fc_1234813798"
      unitRef="uref_1046053354"
      xsi:nil="true"/>
    <ccxi:WorkingCapitalLoan
      contextRef="cref_294760605"
      id="fc_708786138"
      unitRef="uref_1046053354"
      xsi:nil="true"/>
    <us-gaap:PreferredStockSharesIssued
      contextRef="cref_886637457"
      id="fc_1920448683"
      unitRef="uref_1880167681"
      xsi:nil="true"/>
    <us-gaap:PreferredStockSharesOutstanding
      contextRef="cref_294760605"
      id="fc_794424461"
      unitRef="uref_1880167681"
      xsi:nil="true"/>
    <ccxi:WorkingCapitalLoan
      contextRef="cref_294760605"
      id="fc_2098540141"
      unitRef="uref_1046053354"
      xsi:nil="true"/>
    <us-gaap:PreferredStockSharesIssued
      contextRef="cref_294760605"
      id="fc_1362458714"
      unitRef="uref_1880167681"
      xsi:nil="true"/>
    <us-gaap:PreferredStockSharesOutstanding
      contextRef="cref_294760605"
      id="fc_2110305280"
      unitRef="uref_1880167681"
      xsi:nil="true"/>
    <us-gaap:NetIncomeLoss
      contextRef="cref_492134705"
      id="fc_675619141"
      unitRef="uref_1046053354"
      xsi:nil="true"/>
    <us-gaap:NetIncomeLoss
      contextRef="cref_2088266185"
      id="fc_1260442271"
      unitRef="uref_1046053354"
      xsi:nil="true"/>
    <us-gaap:NetIncomeLoss
      contextRef="cref_1070095916"
      id="fc_954540636"
      unitRef="uref_1046053354"
      xsi:nil="true"/>
    <us-gaap:StockholdersEquity
      contextRef="cref_671122245"
      id="fc_671122245"
      unitRef="uref_1046053354"
      xsi:nil="true"/>
    <us-gaap:CashEquivalentsAtCarryingValue
      contextRef="cref_886637457"
      id="fc_1896867140"
      unitRef="uref_1046053354"
      xsi:nil="true"/>
    <us-gaap:UnrecognizedTaxBenefits
      contextRef="cref_886637457"
      id="fc_495639681"
      unitRef="uref_1046053354"
      xsi:nil="true"/>
    <us-gaap:UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued
      contextRef="cref_294760605"
      id="fc_680601104"
      unitRef="uref_1046053354"
      xsi:nil="true"/>
    <ccxi:WorkingCapitalLoan
      contextRef="cref_886637457"
      id="fc_1112016607"
      unitRef="uref_1046053354"
      xsi:nil="true"/>
    <us-gaap:PreferredStockSharesIssued
      contextRef="cref_886637457"
      id="fc_1147257839"
      unitRef="uref_1880167681"
      xsi:nil="true"/>
    <us-gaap:PreferredStockSharesOutstanding
      contextRef="cref_294760605"
      id="fc_1656918921"
      unitRef="uref_1880167681"
      xsi:nil="true"/>
    <us-gaap:SegmentReportingCodmIndividualTitleAndPositionOrGroupOrCommitteeNameExtensibleEnumeration contextRef="cref_1200964243" id="fc_1200964243">http://fasb.org/srt/2026#ChiefExecutiveOfficerMember</us-gaap:SegmentReportingCodmIndividualTitleAndPositionOrGroupOrCommitteeNameExtensibleEnumeration>
    <us-gaap:SegmentReportingCodmIndividualTitleAndPositionOrGroupOrCommitteeNameExtensibleEnumeration contextRef="cref_715216225" id="fc_715216225">http://fasb.org/srt/2026#ChiefFinancialOfficerMember</us-gaap:SegmentReportingCodmIndividualTitleAndPositionOrGroupOrCommitteeNameExtensibleEnumeration>
    <us-gaap:CommitmentsAndContingencies
      contextRef="cref_294760605"
      id="fc_1136111365"
      unitRef="uref_1046053354"
      xsi:nil="true"/>
    <us-gaap:PreferredStockValue
      contextRef="cref_294760605"
      id="fc_709093367"
      unitRef="uref_1046053354"
      xsi:nil="true"/>
    <dei:AmendmentFlag contextRef="cref_598338636" id="ixv-3212">false</dei:AmendmentFlag>
    <dei:EntityCentralIndexKey contextRef="cref_598338636" id="ixv-3213">0002074973</dei:EntityCentralIndexKey>
    <dei:DocumentFiscalPeriodFocus contextRef="cref_598338636" id="ixv-3214">Q1</dei:DocumentFiscalPeriodFocus>
    <dei:CurrentFiscalYearEndDate contextRef="cref_598338636" id="ixv-3215">--12-31</dei:CurrentFiscalYearEndDate>
    <dei:DocumentType contextRef="cref_598338636" id="ixv-3955">10-Q</dei:DocumentType>
    <dei:DocumentQuarterlyReport contextRef="cref_598338636" id="ixv-3956">true</dei:DocumentQuarterlyReport>
    <dei:DocumentPeriodEndDate contextRef="cref_598338636" id="ixv-3957">2026-03-31</dei:DocumentPeriodEndDate>
    <dei:DocumentFiscalYearFocus contextRef="cref_598338636" id="ixv-3958">2026</dei:DocumentFiscalYearFocus>
    <dei:DocumentTransitionReport contextRef="cref_598338636" id="ixv-3959">false</dei:DocumentTransitionReport>
    <dei:EntityFileNumber contextRef="cref_598338636" id="ixv-3960">001-43020</dei:EntityFileNumber>
    <dei:EntityRegistrantName contextRef="cref_598338636" id="ixv-3961">Churchill Capital Corp XI</dei:EntityRegistrantName>
    <dei:EntityIncorporationStateCountryCode contextRef="cref_598338636" id="ixv-3962">E9</dei:EntityIncorporationStateCountryCode>
    <dei:EntityTaxIdentificationNumber contextRef="cref_598338636" id="ixv-3963">86-1959629</dei:EntityTaxIdentificationNumber>
    <dei:EntityAddressAddressLine1 contextRef="cref_598338636" id="ixv-3964">640 Fifth Avenue</dei:EntityAddressAddressLine1>
    <dei:EntityAddressAddressLine2 contextRef="cref_598338636" id="ixv-87">14th Floor</dei:EntityAddressAddressLine2>
    <dei:EntityAddressCityOrTown contextRef="cref_598338636" id="ixv-3965">New York</dei:EntityAddressCityOrTown>
    <dei:EntityAddressStateOrProvince contextRef="cref_598338636" id="ixv-3966">NY</dei:EntityAddressStateOrProvince>
    <dei:EntityAddressPostalZipCode contextRef="cref_598338636" id="ixv-3967">10019</dei:EntityAddressPostalZipCode>
    <dei:CityAreaCode contextRef="cref_598338636" id="ixv-3968">(212)</dei:CityAreaCode>
    <dei:LocalPhoneNumber contextRef="cref_598338636" id="ixv-3969">380-7500</dei:LocalPhoneNumber>
    <dei:Security12bTitle contextRef="cref_1297356631" id="ixv-3970">Units, each consisting of one Class A Ordinary Share and one-tenth of one redeemable Warrant</dei:Security12bTitle>
    <dei:TradingSymbol contextRef="cref_1297356631" id="ixv-3971">CCXIU</dei:TradingSymbol>
    <dei:SecurityExchangeName contextRef="cref_1297356631" id="ixv-3972">NASDAQ</dei:SecurityExchangeName>
    <dei:Security12bTitle contextRef="cref_999510150" id="ixv-3973">Class A Ordinary Shares, par value $0.0001 per share</dei:Security12bTitle>
    <dei:TradingSymbol contextRef="cref_999510150" id="ixv-3974">CCXI</dei:TradingSymbol>
    <dei:SecurityExchangeName contextRef="cref_999510150" id="ixv-3975">NASDAQ</dei:SecurityExchangeName>
    <dei:Security12bTitle contextRef="cref_1581394983" id="ixv-3976">Warrants, each whole Warrant exercisable for one Class A Ordinary Share at an exercise price of $11.50 per share</dei:Security12bTitle>
    <dei:TradingSymbol contextRef="cref_1581394983" id="ixv-3977">CCXIW</dei:TradingSymbol>
    <dei:SecurityExchangeName contextRef="cref_1581394983" id="ixv-3978">NASDAQ</dei:SecurityExchangeName>
    <dei:EntityCurrentReportingStatus contextRef="cref_598338636" id="ixv-3979">Yes</dei:EntityCurrentReportingStatus>
    <dei:EntityInteractiveDataCurrent contextRef="cref_598338636" id="ixv-3980">Yes</dei:EntityInteractiveDataCurrent>
    <dei:EntityFilerCategory contextRef="cref_598338636" id="ixv-3981">Non-accelerated Filer</dei:EntityFilerCategory>
    <dei:EntitySmallBusiness contextRef="cref_598338636" id="ixv-3982">true</dei:EntitySmallBusiness>
    <dei:EntityEmergingGrowthCompany contextRef="cref_598338636" id="ixv-3983">true</dei:EntityEmergingGrowthCompany>
    <dei:EntityExTransitionPeriod contextRef="cref_598338636" id="ixv-3984">false</dei:EntityExTransitionPeriod>
    <dei:EntityShellCompany contextRef="cref_598338636" id="ixv-3985">true</dei:EntityShellCompany>
    <dei:EntityCommonStockSharesOutstanding
      contextRef="cref_1543236063"
      decimals="0"
      id="ixv-3986"
      unitRef="uref_1880167681">41900000</dei:EntityCommonStockSharesOutstanding>
    <dei:EntityCommonStockSharesOutstanding
      contextRef="cref_1299616844"
      decimals="0"
      id="ixv-3987"
      unitRef="uref_1880167681">13800000</dei:EntityCommonStockSharesOutstanding>
    <us-gaap:Cash
      contextRef="cref_886637457"
      decimals="0"
      id="ixv-3988"
      unitRef="uref_1046053354">410097</us-gaap:Cash>
    <us-gaap:Cash
      contextRef="cref_294760605"
      decimals="0"
      id="ixv-3989"
      unitRef="uref_1046053354">736204</us-gaap:Cash>
    <us-gaap:PrepaidInsurance
      contextRef="cref_886637457"
      decimals="0"
      id="ixv-3990"
      unitRef="uref_1046053354">307750</us-gaap:PrepaidInsurance>
    <us-gaap:PrepaidInsurance
      contextRef="cref_294760605"
      decimals="0"
      id="ixv-3991"
      unitRef="uref_1046053354">307750</us-gaap:PrepaidInsurance>
    <us-gaap:OtherPrepaidExpenseCurrent
      contextRef="cref_886637457"
      decimals="0"
      id="ixv-3992"
      unitRef="uref_1046053354">73109</us-gaap:OtherPrepaidExpenseCurrent>
    <us-gaap:OtherPrepaidExpenseCurrent
      contextRef="cref_294760605"
      decimals="0"
      id="ixv-3993"
      unitRef="uref_1046053354">18800</us-gaap:OtherPrepaidExpenseCurrent>
    <us-gaap:AssetsCurrent
      contextRef="cref_886637457"
      decimals="0"
      id="ixv-3994"
      unitRef="uref_1046053354">790956</us-gaap:AssetsCurrent>
    <us-gaap:AssetsCurrent
      contextRef="cref_294760605"
      decimals="0"
      id="ixv-3995"
      unitRef="uref_1046053354">1062754</us-gaap:AssetsCurrent>
    <us-gaap:PrepaidExpenseOtherNoncurrent
      contextRef="cref_886637457"
      decimals="0"
      id="ixv-3996"
      unitRef="uref_1046053354">220058</us-gaap:PrepaidExpenseOtherNoncurrent>
    <us-gaap:PrepaidExpenseOtherNoncurrent
      contextRef="cref_294760605"
      decimals="0"
      id="ixv-3997"
      unitRef="uref_1046053354">296995</us-gaap:PrepaidExpenseOtherNoncurrent>
    <us-gaap:AssetsHeldInTrustNoncurrent
      contextRef="cref_886637457"
      decimals="0"
      id="ixv-3998"
      unitRef="uref_1046053354">418094829</us-gaap:AssetsHeldInTrustNoncurrent>
    <us-gaap:AssetsHeldInTrustNoncurrent
      contextRef="cref_294760605"
      decimals="0"
      id="ixv-3999"
      unitRef="uref_1046053354">414549783</us-gaap:AssetsHeldInTrustNoncurrent>
    <us-gaap:Assets
      contextRef="cref_886637457"
      decimals="0"
      id="ixv-4000"
      unitRef="uref_1046053354">419105843</us-gaap:Assets>
    <us-gaap:Assets
      contextRef="cref_294760605"
      decimals="0"
      id="ixv-4001"
      unitRef="uref_1046053354">415909532</us-gaap:Assets>
    <us-gaap:AccruedLiabilitiesCurrent
      contextRef="cref_886637457"
      decimals="0"
      id="ixv-4002"
      unitRef="uref_1046053354">80605</us-gaap:AccruedLiabilitiesCurrent>
    <us-gaap:AccruedLiabilitiesCurrent
      contextRef="cref_294760605"
      decimals="0"
      id="ixv-4003"
      unitRef="uref_1046053354">55667</us-gaap:AccruedLiabilitiesCurrent>
    <ccxi:AccruedOfferingCostsCurrent
      contextRef="cref_886637457"
      decimals="0"
      id="ixv-4004"
      unitRef="uref_1046053354">75000</ccxi:AccruedOfferingCostsCurrent>
    <ccxi:AccruedOfferingCostsCurrent
      contextRef="cref_294760605"
      decimals="0"
      id="ixv-4005"
      unitRef="uref_1046053354">75000</ccxi:AccruedOfferingCostsCurrent>
    <us-gaap:LiabilitiesCurrent
      contextRef="cref_886637457"
      decimals="0"
      id="ixv-4006"
      unitRef="uref_1046053354">155605</us-gaap:LiabilitiesCurrent>
    <us-gaap:LiabilitiesCurrent
      contextRef="cref_294760605"
      decimals="0"
      id="ixv-4007"
      unitRef="uref_1046053354">130667</us-gaap:LiabilitiesCurrent>
    <ccxi:DeferredUnderwritingFeeNoncurrent
      contextRef="cref_886637457"
      decimals="0"
      id="ixv-4008"
      unitRef="uref_1046053354">15990000</ccxi:DeferredUnderwritingFeeNoncurrent>
    <ccxi:DeferredUnderwritingFeeNoncurrent
      contextRef="cref_294760605"
      decimals="0"
      id="ixv-4009"
      unitRef="uref_1046053354">15990000</ccxi:DeferredUnderwritingFeeNoncurrent>
    <us-gaap:Liabilities
      contextRef="cref_886637457"
      decimals="0"
      id="ixv-4010"
      unitRef="uref_1046053354">16145605</us-gaap:Liabilities>
    <us-gaap:Liabilities
      contextRef="cref_294760605"
      decimals="0"
      id="ixv-4011"
      unitRef="uref_1046053354">16120667</us-gaap:Liabilities>
    <us-gaap:TemporaryEquitySharesIssued
      contextRef="cref_438597182"
      decimals="0"
      id="ixv-4012"
      unitRef="uref_1880167681">41400000</us-gaap:TemporaryEquitySharesIssued>
    <us-gaap:TemporaryEquitySharesIssued
      contextRef="cref_165471328"
      decimals="0"
      id="ixv-4013"
      unitRef="uref_1880167681">41400000</us-gaap:TemporaryEquitySharesIssued>
    <us-gaap:TemporaryEquityRedemptionPricePerShare
      contextRef="cref_438597182"
      decimals="2"
      id="ixv-4014"
      unitRef="uref_123589252">10.07</us-gaap:TemporaryEquityRedemptionPricePerShare>
    <us-gaap:TemporaryEquityRedemptionPricePerShare
      contextRef="cref_165471328"
      decimals="2"
      id="ixv-4015"
      unitRef="uref_123589252">10</us-gaap:TemporaryEquityRedemptionPricePerShare>
    <us-gaap:TemporaryEquityCarryingAmountAttributableToParent
      contextRef="cref_886637457"
      decimals="0"
      id="ixv-4016"
      unitRef="uref_1046053354">417094829</us-gaap:TemporaryEquityCarryingAmountAttributableToParent>
    <us-gaap:TemporaryEquityCarryingAmountAttributableToParent
      contextRef="cref_294760605"
      decimals="0"
      id="ixv-4017"
      unitRef="uref_1046053354">414000000</us-gaap:TemporaryEquityCarryingAmountAttributableToParent>
    <us-gaap:PreferredStockParOrStatedValuePerShare
      contextRef="cref_886637457"
      decimals="4"
      id="ixv-4018"
      unitRef="uref_123589252">0.0001</us-gaap:PreferredStockParOrStatedValuePerShare>
    <us-gaap:PreferredStockParOrStatedValuePerShare
      contextRef="cref_294760605"
      decimals="4"
      id="ixv-4019"
      unitRef="uref_123589252">0.0001</us-gaap:PreferredStockParOrStatedValuePerShare>
    <us-gaap:PreferredStockSharesAuthorized
      contextRef="cref_886637457"
      decimals="0"
      id="ixv-4020"
      unitRef="uref_1880167681">5000000</us-gaap:PreferredStockSharesAuthorized>
    <us-gaap:PreferredStockSharesAuthorized
      contextRef="cref_294760605"
      decimals="0"
      id="ixv-4021"
      unitRef="uref_1880167681">5000000</us-gaap:PreferredStockSharesAuthorized>
    <us-gaap:CommonStockParOrStatedValuePerShare
      contextRef="cref_438597182"
      decimals="4"
      id="ixv-4022"
      unitRef="uref_123589252">0.0001</us-gaap:CommonStockParOrStatedValuePerShare>
    <us-gaap:CommonStockParOrStatedValuePerShare
      contextRef="cref_165471328"
      decimals="4"
      id="ixv-4023"
      unitRef="uref_123589252">0.0001</us-gaap:CommonStockParOrStatedValuePerShare>
    <us-gaap:CommonStockSharesAuthorized
      contextRef="cref_438597182"
      decimals="0"
      id="ixv-4024"
      unitRef="uref_1880167681">500000000</us-gaap:CommonStockSharesAuthorized>
    <us-gaap:CommonStockSharesAuthorized
      contextRef="cref_165471328"
      decimals="0"
      id="ixv-4025"
      unitRef="uref_1880167681">500000000</us-gaap:CommonStockSharesAuthorized>
    <us-gaap:CommonStockSharesIssued
      contextRef="cref_438597182"
      decimals="0"
      id="ixv-4026"
      unitRef="uref_1880167681">500000</us-gaap:CommonStockSharesIssued>
    <us-gaap:CommonStockSharesOutstanding
      contextRef="cref_438597182"
      decimals="0"
      id="ixv-4027"
      unitRef="uref_1880167681">500000</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:CommonStockSharesIssued
      contextRef="cref_165471328"
      decimals="0"
      id="ixv-4028"
      unitRef="uref_1880167681">500000</us-gaap:CommonStockSharesIssued>
    <us-gaap:CommonStockSharesOutstanding
      contextRef="cref_165471328"
      decimals="0"
      id="ixv-4029"
      unitRef="uref_1880167681">500000</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:CommonStockValue
      contextRef="cref_438597182"
      decimals="0"
      id="ixv-4030"
      unitRef="uref_1046053354">50</us-gaap:CommonStockValue>
    <us-gaap:CommonStockValue
      contextRef="cref_165471328"
      decimals="0"
      id="ixv-4031"
      unitRef="uref_1046053354">50</us-gaap:CommonStockValue>
    <us-gaap:CommonStockParOrStatedValuePerShare
      contextRef="cref_51160283"
      decimals="4"
      id="fc_1161663313"
      unitRef="uref_123589252">0.0001</us-gaap:CommonStockParOrStatedValuePerShare>
    <us-gaap:CommonStockParOrStatedValuePerShare
      contextRef="cref_107229769"
      decimals="4"
      id="ixv-4033"
      unitRef="uref_123589252">0.0001</us-gaap:CommonStockParOrStatedValuePerShare>
    <us-gaap:CommonStockSharesAuthorized
      contextRef="cref_51160283"
      decimals="0"
      id="fc_2026219567"
      unitRef="uref_1880167681">50000000</us-gaap:CommonStockSharesAuthorized>
    <us-gaap:CommonStockSharesAuthorized
      contextRef="cref_107229769"
      decimals="0"
      id="ixv-4035"
      unitRef="uref_1880167681">50000000</us-gaap:CommonStockSharesAuthorized>
    <us-gaap:CommonStockSharesIssued
      contextRef="cref_51160283"
      decimals="0"
      id="fc_227282861"
      unitRef="uref_1880167681">13800000</us-gaap:CommonStockSharesIssued>
    <us-gaap:CommonStockSharesOutstanding
      contextRef="cref_51160283"
      decimals="0"
      id="ixv-4037"
      unitRef="uref_1880167681">13800000</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:CommonStockSharesIssued
      contextRef="cref_107229769"
      decimals="0"
      id="ixv-4038"
      unitRef="uref_1880167681">13800000</us-gaap:CommonStockSharesIssued>
    <us-gaap:CommonStockSharesOutstanding
      contextRef="cref_107229769"
      decimals="0"
      id="ixv-4039"
      unitRef="uref_1880167681">13800000</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:CommonStockValue
      contextRef="cref_51160283"
      decimals="0"
      id="ixv-4040"
      unitRef="uref_1046053354">1380</us-gaap:CommonStockValue>
    <us-gaap:CommonStockValue
      contextRef="cref_107229769"
      decimals="0"
      id="ixv-4041"
      unitRef="uref_1046053354">1380</us-gaap:CommonStockValue>
    <us-gaap:RetainedEarningsAccumulatedDeficit
      contextRef="cref_886637457"
      decimals="0"
      id="ixv-4042"
      unitRef="uref_1046053354">-14136021</us-gaap:RetainedEarningsAccumulatedDeficit>
    <us-gaap:RetainedEarningsAccumulatedDeficit
      contextRef="cref_294760605"
      decimals="0"
      id="ixv-4043"
      unitRef="uref_1046053354">-14212565</us-gaap:RetainedEarningsAccumulatedDeficit>
    <us-gaap:StockholdersEquity
      contextRef="cref_886637457"
      decimals="0"
      id="ixv-4044"
      unitRef="uref_1046053354">-14134591</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="cref_294760605"
      decimals="0"
      id="ixv-4045"
      unitRef="uref_1046053354">-14211135</us-gaap:StockholdersEquity>
    <us-gaap:LiabilitiesAndStockholdersEquity
      contextRef="cref_886637457"
      decimals="0"
      id="ixv-4046"
      unitRef="uref_1046053354">419105843</us-gaap:LiabilitiesAndStockholdersEquity>
    <us-gaap:LiabilitiesAndStockholdersEquity
      contextRef="cref_294760605"
      decimals="0"
      id="ixv-4047"
      unitRef="uref_1046053354">415909532</us-gaap:LiabilitiesAndStockholdersEquity>
    <us-gaap:GeneralAndAdministrativeExpense
      contextRef="cref_598338636"
      decimals="0"
      id="ixv-4048"
      unitRef="uref_1046053354">373673</us-gaap:GeneralAndAdministrativeExpense>
    <us-gaap:OperatingIncomeLoss
      contextRef="cref_598338636"
      decimals="0"
      id="ixv-4049"
      unitRef="uref_1046053354">-373673</us-gaap:OperatingIncomeLoss>
    <us-gaap:InvestmentIncomeInterest
      contextRef="cref_598338636"
      decimals="0"
      id="ixv-4050"
      unitRef="uref_1046053354">3545046</us-gaap:InvestmentIncomeInterest>
    <us-gaap:NonoperatingIncomeExpense
      contextRef="cref_598338636"
      decimals="0"
      id="ixv-4051"
      unitRef="uref_1046053354">3545046</us-gaap:NonoperatingIncomeExpense>
    <us-gaap:NetIncomeLoss
      contextRef="cref_598338636"
      decimals="0"
      id="ixv-4052"
      unitRef="uref_1046053354">3171373</us-gaap:NetIncomeLoss>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="cref_1083338889"
      decimals="0"
      id="ixv-4053"
      unitRef="uref_1880167681">41900000</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:EarningsPerShareBasic
      contextRef="cref_1083338889"
      decimals="2"
      id="ixv-4054"
      unitRef="uref_123589252">0.06</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareDiluted
      contextRef="cref_1083338889"
      decimals="2"
      id="ixv-4055"
      unitRef="uref_123589252">0.06</us-gaap:EarningsPerShareDiluted>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="cref_1326103014"
      decimals="0"
      id="ixv-4056"
      unitRef="uref_1880167681">13800000</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:EarningsPerShareBasic
      contextRef="cref_1326103014"
      decimals="2"
      id="ixv-4057"
      unitRef="uref_123589252">0.06</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareDiluted
      contextRef="cref_1326103014"
      decimals="2"
      id="ixv-4058"
      unitRef="uref_123589252">0.06</us-gaap:EarningsPerShareDiluted>
    <us-gaap:SharesOutstanding
      contextRef="cref_2052403743"
      decimals="0"
      id="fc_899761700"
      unitRef="uref_1880167681">500000</us-gaap:SharesOutstanding>
    <us-gaap:StockholdersEquity
      contextRef="cref_2052403743"
      decimals="0"
      id="fc_2052403743"
      unitRef="uref_1046053354">50</us-gaap:StockholdersEquity>
    <us-gaap:SharesOutstanding
      contextRef="cref_1163785961"
      decimals="0"
      id="fc_648437601"
      unitRef="uref_1880167681">13800000</us-gaap:SharesOutstanding>
    <us-gaap:StockholdersEquity
      contextRef="cref_1163785961"
      decimals="0"
      id="fc_1163785961"
      unitRef="uref_1046053354">1380</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="cref_1910314510"
      decimals="0"
      id="fc_1910314510"
      unitRef="uref_1046053354">-14212565</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="cref_294760605"
      decimals="0"
      id="fc_811135186"
      unitRef="uref_1046053354">-14211135</us-gaap:StockholdersEquity>
    <us-gaap:TemporaryEquityAccretionToRedemptionValue
      contextRef="cref_993580423"
      decimals="0"
      id="ixv-4065"
      unitRef="uref_1046053354">3094829</us-gaap:TemporaryEquityAccretionToRedemptionValue>
    <us-gaap:TemporaryEquityAccretionToRedemptionValue
      contextRef="cref_598338636"
      decimals="0"
      id="ixv-4066"
      unitRef="uref_1046053354">3094829</us-gaap:TemporaryEquityAccretionToRedemptionValue>
    <us-gaap:NetIncomeLoss
      contextRef="cref_993580423"
      decimals="0"
      id="ixv-4067"
      unitRef="uref_1046053354">3171373</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="cref_598338636"
      decimals="0"
      id="ixv-4068"
      unitRef="uref_1046053354">3171373</us-gaap:NetIncomeLoss>
    <us-gaap:SharesOutstanding
      contextRef="cref_235862386"
      decimals="0"
      id="ixv-4069"
      unitRef="uref_1880167681">500000</us-gaap:SharesOutstanding>
    <us-gaap:StockholdersEquity
      contextRef="cref_235862386"
      decimals="0"
      id="ixv-4070"
      unitRef="uref_1046053354">50</us-gaap:StockholdersEquity>
    <us-gaap:SharesOutstanding
      contextRef="cref_233192784"
      decimals="0"
      id="ixv-4071"
      unitRef="uref_1880167681">13800000</us-gaap:SharesOutstanding>
    <us-gaap:StockholdersEquity
      contextRef="cref_233192784"
      decimals="0"
      id="ixv-4072"
      unitRef="uref_1046053354">1380</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="cref_211675031"
      decimals="0"
      id="ixv-4073"
      unitRef="uref_1046053354">-14136021</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="cref_886637457"
      decimals="0"
      id="ixv-4074"
      unitRef="uref_1046053354">-14134591</us-gaap:StockholdersEquity>
    <us-gaap:NetIncomeLoss
      contextRef="cref_598338636"
      decimals="0"
      id="ixv-4075"
      unitRef="uref_1046053354">3171373</us-gaap:NetIncomeLoss>
    <us-gaap:InvestmentIncomeInterest
      contextRef="cref_598338636"
      decimals="0"
      id="ixv-4076"
      unitRef="uref_1046053354">3545046</us-gaap:InvestmentIncomeInterest>
    <us-gaap:IncreaseDecreaseInPrepaidExpense
      contextRef="cref_598338636"
      decimals="0"
      id="fc_1299458828"
      unitRef="uref_1046053354">54309</us-gaap:IncreaseDecreaseInPrepaidExpense>
    <ccxi:IncreaseDecreaseInLongTermPrepaidInsurance
      contextRef="cref_598338636"
      decimals="0"
      id="fc_297313893"
      unitRef="uref_1046053354">-76937</ccxi:IncreaseDecreaseInLongTermPrepaidInsurance>
    <us-gaap:IncreaseDecreaseInAccruedLiabilities
      contextRef="cref_598338636"
      decimals="0"
      id="fc_939716387"
      unitRef="uref_1046053354">24938</us-gaap:IncreaseDecreaseInAccruedLiabilities>
    <us-gaap:NetCashProvidedByUsedInOperatingActivities
      contextRef="cref_598338636"
      decimals="0"
      id="ixv-4080"
      unitRef="uref_1046053354">-326107</us-gaap:NetCashProvidedByUsedInOperatingActivities>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
      contextRef="cref_598338636"
      decimals="0"
      id="ixv-4081"
      unitRef="uref_1046053354">-326107</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="cref_294760605"
      decimals="0"
      id="ixv-4082"
      unitRef="uref_1046053354">736204</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="cref_886637457"
      decimals="0"
      id="ixv-4083"
      unitRef="uref_1046053354">410097</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock contextRef="cref_598338636" id="ixv-1846">&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;span style="font-weight: bold;"&gt;&lt;span id="a_007" style="display: inline-block;"&gt;&lt;/span&gt;Note&#160;1 &#x2014;&#160;Organization and Business Operations&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 29.15pt"&gt;&lt;span style="font-weight: bold;"&gt;&lt;i&gt;&#160;&lt;/i&gt;&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;span style="font-weight: bold;"&gt;&lt;i&gt;Organization and General&lt;/i&gt;&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 29.15pt; text-indent: 17.45pt"&gt;&#160;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt; Churchill Capital Corp&#160;XI (the &#x201c;Company&#x201d;) was incorporated as a Cayman Islands exempted company on June&#160;4, 2025. The Company was incorporated for the purpose of effecting a merger, amalgamation, share exchange, asset acquisition, share purchase, reorganization or similar business combination with one or more businesses that the Company has not yet identified (the &#x201c;Business Combination&#x201d;). The Company is an &#x201c;emerging growth company,&#x201d; as defined in Section&#160;2(a)&#160;of the Securities Act&#160;of&#160;1933, as amended, or the &#x201c;Securities Act,&#x201d; as modified by the Jumpstart Our Business Startups Act&#160;of&#160;2012 (the &#x201c;JOBS Act&#x201d;). &lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 29.15pt; text-indent: 17.45pt"&gt;&#160;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;As of March 31, 2026, the Company had not yet commenced operations. All activity for the period from June&#160;4, 2025 (inception) through March 31, 2026 relates to (i) the Company&#x2019;s formation and the Initial Public Offering (as defined below), and (ii) subsequent to the Initial Public Offering, identifying a target company for an initial Business Combination., which is described below. The Company will not generate any operating revenues until after the completion of its initial Business Combination, at the earliest. The Company generates non-operating income in the form of interest income from the proceeds derived from the Initial Public Offering. The Company has selected December&#160;31 as its fiscal year end.&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;span style="font-weight: bold;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;span style="font-weight: bold;"&gt;&lt;i&gt;Sponsor and Initial Public Offering&lt;/i&gt;&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 29.15pt; text-indent: 17.45pt"&gt;&#160;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt; The Company&#x2019;s sponsor is Churchill Sponsor&#160;XI LLC (the &#x201c;Sponsor&#x201d;), an affiliate of M. Klein and Company, LLC. The Registration Statement on Form S-1 for the Initial Public Offering, initially filed with the U.S. Securities and Exchange Commission (the &#x201c;SEC&#x201d;) on November 18, 2025 (File No. 333-291626), was declared effective on December 16, 2025 (as amended, and together with the registration statement on Form S-1MEF (File No. 333-292183) filed with the SEC on December 16, 2025, which became effective upon filing, the &#x201c;IPO Registration Statement&#x201d;). On December 18, 2025, the Company consummated the Initial Public Offering of 41,400,000&#160;units at $10.00 per unit (the &#x201c;Public Units&#x201d;), which includes the full exercise of the underwriter&#x2019;s Over-Allotment Option (as defined in Note 6) in the amount of 5,400,000&#160;units (the &#x201c;Option Units&#x201d;) at $10.00 per Option Unit (Note&#160;3), generating gross proceeds of $414,000,000 (the &#x201c;Initial Public Offering&#x201d;). Each Public Unit consists of one Class A Ordinary Share, par value $0.0001 per share, of the Company (the &#x201c;Class A Ordinary Shares&#x201d; and with respect to the Class A Ordinary Shares included in the Public Units, the &#x201c;Public Shares&#x201d;) and one-tenth of one redeemable warrant (each, a &#x201c;Public Warrant&#x201d;). Simultaneously, the Company consummated the sale of 500,000 units (the &#x201c;Private Placement Units&#x201d;) (Note&#160;4), at a price of $10.00 per Private Placement Unit in a private placement to the Sponsor, generating gross proceeds of $5,000,000 (the &#x201c;Private Placement&#x201d;). Each Private Placement Unit consists of one Class A Ordinary Share and one-tenth of one redeemable warrant (the &#x201c;Private Placement Warrants&#x201d; and together with the Public Warrants, the &#x201c;Warrants&#x201d;). Each whole warrant entitles the holder to purchase one Class A Ordinary Share at a price of $11.50, subject to adjustment. &lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 29.15pt; text-indent: 17.45pt"&gt;&#160;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt; Transaction costs amounted to $19,618,232, consisting of $3,000,000 of cash underwriting fees (net of $3,210,000 underwriter&#x2019;s reimbursement), $15,990,000 of Deferred Fee (as defined in Note 2), and $628,232 of other offering costs. &lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 29.15pt"&gt;&lt;span style="font-weight: bold;"&gt;&lt;i&gt;&#160;&lt;/i&gt;&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;span style="font-weight: bold;"&gt;&lt;i&gt;The Trust Account&lt;/i&gt;&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 29.15pt; text-indent: 17.45pt"&gt;&#160;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt; Following the closing of the Initial Public Offering on December 18, 2025, an amount of $414,000,000 ($10.00 per Unit) from the net proceeds of the sale of the Units in the Initial Public Offering, and a portion of the proceeds of the sale of the Private Placement Units in the Private Placement, was placed in a Trust Account (the &#x201c;Trust Account&#x201d;). The proceeds held in the Trust Account are invested only in U.S.&#160;government treasury bills with a maturity of one hundred eighty-five (185)&#160;days or less or in money market funds that meet certain conditions under Rule&#160;2a-7 under the Investment Company Act&#160;of&#160;1940 (the &#x201c;Investment Company Act&#x201d;) and that invest only in direct U.S.&#160;government obligations and, may at any time be held as cash or cash items, including in demand deposit accounts at a bank. Funds will remain in the Trust Account until the earlier of (i)&#160;the consummation of the initial Business Combination or (ii)&#160;the distribution of the Trust Account proceeds as described below. The remaining proceeds outside the Trust Account may be used to pay for business, legal and accounting due diligence on prospective acquisitions and continuing general and administrative expenses. &lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&#160;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt; The Company&#x2019;s amended and restated memorandum and articles of association (the &#x201c;Amended and Restated Articles&#x201d;) provides that, other than the permitted withdrawals (as defined below), if any, none of the funds held in the Trust Account will be released until the earlier of (i)&#160;the completion of the initial Business Combination; (ii)&#160;the redemption of any Public Shares, that have been properly submitted in connection with a shareholder vote to approve an amendment to the Company&#x2019;s Amended and Restated Articles (A)&#160;in a manner that would affect the substance or timing of its obligation to redeem 100% of the Public Shares if it does not complete an initial Business Combination within 24&#160;months from the closing of the Initial Public Offering (or 27&#160;months from the closing of the Initial Public Offering if the Company has executed a letter of intent, agreement in principle or definitive agreement for an initial Business Combination within 24&#160;months from the closing of the Initial Public Offering) (the &#x201c;Combination Period&#x201d;) or (B)&#160;with respect to any other provision relating to the rights of holders of the Public Shares or pre-initial Business Combination activity; and (iii)&#160;the redemption of 100% of the Public Shares if the Company is unable to complete an initial Business Combination within the Combination Period. The proceeds deposited in the Trust Account could become subject to the claims of the Company&#x2019;s creditors, if any, which could have priority over the claims of the Company&#x2019;s public shareholders. &lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 14.55pt"&gt;&#160;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;span style="font-weight: bold;"&gt;&lt;i&gt;Initial Business Combination&lt;/i&gt;&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 29.15pt; text-indent: 17.45pt"&gt;&#160;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt; The Company&#x2019;s management has broad discretion with respect to the specific application of the net proceeds of the Initial Public Offering, although substantially all of the net proceeds of the Initial Public Offering are intended to be generally applied toward consummating an initial Business Combination. The initial Business Combination must occur with one or more target businesses that together have an aggregate fair market value of at least 80% of the assets held in the Trust Account (excluding the Deferred Fee (as defined below) and taxes payable on income earned on the Trust Account) at the time of the agreement to enter into the initial Business Combination. Furthermore, there is no assurance that the Company will be able to successfully effect an initial Business Combination. &lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt; The Company, after signing a definitive agreement for an initial Business Combination, will either (i)&#160;seek shareholder approval of the initial Business Combination at a meeting called for such purpose in connection with which shareholders may seek to redeem their shares, regardless of whether they vote for or against the initial Business Combination, for cash equal to their pro rata share of the aggregate amount then on deposit in the Trust Account as of two&#160;business days prior to the consummation of the initial Business Combination, including interest earned on the funds held in the trust account (net of amounts withdrawn to fund the working capital requirements, subject to an annual limit of $1,000,000, and to pay taxes (&#x201c;permitted withdrawals&#x201d;)), (ii)&#160;provide shareholders with the opportunity to sell their Public Shares to the Company by means of a tender offer (and thereby avoid the need for a shareholder vote) for an amount in cash equal to their pro rata share of the aggregate amount then on deposit in the Trust Account as of two&#160;business days prior to the consummation of the initial Business Combination, including interest less permitted withdrawals. The decision as to whether the Company will seek shareholder approval of the initial Business Combination or will allow shareholders to sell their Public Shares in a tender offer will be made by the Company, solely in its discretion, and will be based on a variety of factors such as the timing of the transaction and whether the terms of the transaction would otherwise require the Company to seek shareholder approval, unless a vote is required by law or under Nasdaq rules. &lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 29.15pt; text-indent: 17.45pt"&gt;&#160;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt; Pursuant to the Company&#x2019;s Amended and Restated Articles, if the Company is unable to complete the initial Business Combination within the Combination Period, the Company will (i)&#160;cease all operations except for the purpose of winding up, (ii)&#160;as promptly as reasonably possible but no more than ten&#160;business days thereafter subject to lawfully available funds therefor, redeem the Public Shares, at a per-share price, payable in cash, equal to the aggregate amount then on deposit in the Trust Account including interest earned (which interest shall be net of permitted withdrawals and up to $100,000 of interest to pay dissolution expenses), divided by the number of then outstanding Public Shares, which redemption will completely extinguish the holders&#x2019; rights as shareholders (including the right to receive further liquidating distributions, if any), subject to applicable law, and (iii)&#160;as promptly as reasonably possible following such redemption, subject to the approval of the Company&#x2019;s remaining shareholders and the Company&#x2019;s Board of Directors, dissolve and liquidate, subject in each case to the Company&#x2019;s obligations under Cayman Islands law to provide for claims of creditors and the requirements of other applicable law. The Sponsor, officers and directors are not entitled to rights to liquidating distributions from the Trust Account with respect to any Founder Shares (as defined below) held by them if the Company fails to complete the initial Business Combination within the Combination Period. However, if the Sponsor and management team acquire Public Shares in or after the Initial Public Offering, they are entitled to liquidating distributions from the Trust Account with respect to such shares if the Company fails to complete the initial Business Combination within the Combination Period. The Class A Ordinary Shares subject to redemption will be recorded at a redemption value and classified as temporary equity upon the completion of the Initial Public Offering, in accordance with Financial Accounting Standards Board&#x2019;s (&#x201c;FASB&#x201d;) Accounting Standards Codification (&#x201c;ASC&#x201d;) Topic 480, &#x201c;Distinguishing Liabilities from Equity.&#x201d; &lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 29.15pt"&gt;&#160;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;In the event of a liquidation, dissolution or winding up of the Company after an initial Business Combination, the Company&#x2019;s shareholders are entitled to share ratably in all assets remaining available for distribution after payment of liabilities and after provision is made for each class of shares, if any, having preference over the Ordinary Shares. The Company&#x2019;s shareholders have no preemptive or other subscription rights. There are no sinking fund provisions applicable to the Ordinary Shares, except that the Company will provide its shareholders with the opportunity to redeem their Public Shares for cash equal to their pro rata share of the aggregate amount then on deposit in the Trust Account, upon the completion of the initial Business Combination, subject to the limitations described herein.&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-weight: bold;"&gt;&lt;i&gt;Risks and Uncertainties&lt;/i&gt;&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 11.25pt; text-align: justify"&gt;&#160;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;The Company&#x2019;s ability to complete an initial Business Combination may be adversely affected by various factors, many of which are beyond the Company&#x2019;s control. The Company&#x2019;s ability to consummate an initial Business Combination could be impacted by, among other things, changes in laws or regulations, downturns in the financial markets or in economic conditions, inflation, fluctuations in interest rates, increases in tariffs, supply chain disruptions, declines in consumer confidence and spending, public health considerations, and geopolitical instability, such as the military conflicts in Ukraine, between the United States, Israel and Iran and other in the Middle East, and Southwest Asia or other armed hostilities. The Company cannot at this time predict the likelihood of one or more of the above events, their duration or magnitude or the extent to which they may negatively impact the Company&#x2019;s ability to complete an initial Business Combination.&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;span style="font-weight: bold;"&gt;&lt;i&gt;Liquidity and Capital Resources&lt;/i&gt;&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 29.15pt; text-indent: 17.45pt"&gt;&#160;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt; As of March 31, 2026, the Company had $410,097 of cash and a working capital surplus of $635,351. In order to finance transaction costs in connection with its initial Business Combination, the Sponsor or an affiliate of the Sponsor, or the Company&#x2019;s officers and directors may, but are not obligated to, loan the Company funds as may be required (&#x201c;Working Capital Loans&#x201d;). If the Company completes its initial Business Combination, the Company would repay the Working Capital Loans. In the event that the initial Business Combination does not close, the Company may use a portion of proceeds held outside the Trust Account to repay the Working Capital Loans but no proceeds held in the Trust Account would be used to repay the Working Capital Loans. If the Sponsor makes any Working Capital Loans, up to $1,500,000 of such loans may be convertible into units of the post Business Combination entity at a price of $10.00 per unit at the option of the lender. The units and the underlying securities would be identical to the Private Placement Units. As of March 31, 2026 and December 31, 2025, the Company had &lt;span style="-sec-ix-hidden:fc_1112016607"&gt;&lt;span style="-sec-ix-hidden:fc_2098540141"&gt;no&lt;/span&gt;&lt;/span&gt; borrowings under the Working Capital Loans. &lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt; Additionally, to fund working capital, the Company has permitted withdrawals available up to an annual limit of $1,000,000. These permitted withdrawals are limited to only the interest available that has been earned in excess of the initial deposit at the Initial Public Offering. For the three months ended March 31, 2026, the Company did not withdraw any amounts from the Trust Account for working capital purposes. As of March 31, 2026 the Company had $1,000,000 available for permitted withdraws for the period from December 18, 2025 until December 18, 2026, which is the 1-year anniversary of the Initial Public Offering. &lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;span style="font-weight: bold;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;In connection with the Company&#x2019;s assessment of going concern considerations in accordance with ASC 205-40, &#x201c;Going Concern,&#x201d; as of March 31, 2026, the Company has sufficient funds for the working capital needs of the Company until a minimum of one year from the date of these unaudited condensed financial statements. The Company cannot assure that its plans to consummate an initial Business Combination will be successful.&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;Moreover, the Company may need to obtain additional financing either to complete its Business Combination or because the Company becomes obligated to redeem a significant number of Public Shares upon completion of the Business Combination, in which case the Company may issue additional securities or incur debt in connection with such Business Combination. Accordingly, the Company may not be able to obtain additional financing. If the Company is unable to raise additional capital, it may be required to take additional measures to conserve liquidity, which could include, but not necessarily be limited to, curtailing operations, suspending the pursuit of a potential transaction, and reducing overhead expenses. The Company cannot provide any assurance that new financing will be available to it on commercially acceptable terms, if at all. Accordingly, the Company may not be able to obtain additional financing. If the Company is unable to raise additional capital, it may be required to take additional measures to conserve liquidity, which could include, but not necessarily be limited to, curtailing operations, suspending the pursuit of a potential transaction, and reducing overhead expenses. The Company cannot provide any assurance that new financing will be available to it on commercially acceptable terms, if at all.&lt;/p&gt;</us-gaap:OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock>
    <dei:EntityIncorporationDateOfIncorporation contextRef="cref_598338636" id="ixv-4084">2025-06-04</dei:EntityIncorporationDateOfIncorporation>
    <ccxi:UnitsIssuedDuringPeriodSharesNewIssues
      contextRef="cref_360949448"
      decimals="0"
      id="ixv-4085"
      unitRef="uref_1880167681">41400000</ccxi:UnitsIssuedDuringPeriodSharesNewIssues>
    <us-gaap:SharesIssuedPricePerShare
      contextRef="cref_1387385282"
      decimals="2"
      id="ixv-4086"
      unitRef="uref_123589252">10</us-gaap:SharesIssuedPricePerShare>
    <ccxi:UnitsIssuedDuringPeriodSharesNewIssues
      contextRef="cref_1439813851"
      decimals="0"
      id="ixv-4087"
      unitRef="uref_1880167681">5400000</ccxi:UnitsIssuedDuringPeriodSharesNewIssues>
    <us-gaap:SharesIssuedPricePerShare
      contextRef="cref_426171136"
      decimals="2"
      id="ixv-4088"
      unitRef="uref_123589252">10</us-gaap:SharesIssuedPricePerShare>
    <us-gaap:ProceedsFromIssuanceInitialPublicOffering
      contextRef="cref_675931165"
      decimals="0"
      id="ixv-4089"
      unitRef="uref_1046053354">414000000</us-gaap:ProceedsFromIssuanceInitialPublicOffering>
    <ccxi:NumberOfOrdinarySharesUnits
      contextRef="cref_1387385282"
      decimals="0"
      id="ixv-4090"
      unitRef="uref_1880167681">1</ccxi:NumberOfOrdinarySharesUnits>
    <us-gaap:CommonStockParOrStatedValuePerShare
      contextRef="cref_442909652"
      decimals="4"
      id="ixv-4091"
      unitRef="uref_123589252">0.0001</us-gaap:CommonStockParOrStatedValuePerShare>
    <ccxi:NumberOfRedeemableWarrant
      contextRef="cref_229853459"
      decimals="0"
      id="ixv-4092"
      unitRef="uref_1880167681">1</ccxi:NumberOfRedeemableWarrant>
    <ccxi:UnitsIssuedDuringPeriodSharesNewIssues
      contextRef="cref_882498764"
      decimals="0"
      id="fc_882498764"
      unitRef="uref_1880167681">500000</ccxi:UnitsIssuedDuringPeriodSharesNewIssues>
    <us-gaap:SaleOfStockPricePerShare
      contextRef="cref_1528584890"
      decimals="2"
      id="ixv-4094"
      unitRef="uref_123589252">10</us-gaap:SaleOfStockPricePerShare>
    <us-gaap:ProceedsFromIssuanceOfPrivatePlacement
      contextRef="cref_508538335"
      decimals="0"
      id="fc_508538335"
      unitRef="uref_1046053354">5000000</us-gaap:ProceedsFromIssuanceOfPrivatePlacement>
    <ccxi:NumberOfOrdinarySharesUnits
      contextRef="cref_2002993252"
      decimals="0"
      id="ixv-4096"
      unitRef="uref_1880167681">1</ccxi:NumberOfOrdinarySharesUnits>
    <ccxi:NumberOfRedeemableWarrant
      contextRef="cref_1625903985"
      decimals="0"
      id="ixv-4097"
      unitRef="uref_1880167681">1</ccxi:NumberOfRedeemableWarrant>
    <us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
      contextRef="cref_1545553815"
      decimals="2"
      id="ixv-4098"
      unitRef="uref_123589252">11.5</us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1>
    <ccxi:TransactionCosts
      contextRef="cref_598338636"
      decimals="0"
      id="ixv-4099"
      unitRef="uref_1046053354">19618232</ccxi:TransactionCosts>
    <ccxi:CashUnderwritingFee
      contextRef="cref_598338636"
      decimals="0"
      id="ixv-4100"
      unitRef="uref_1046053354">3000000</ccxi:CashUnderwritingFee>
    <ccxi:ProceedsFromSaleOfUnderwritersReimbursement
      contextRef="cref_598338636"
      decimals="0"
      id="ixv-4101"
      unitRef="uref_1046053354">-3210000</ccxi:ProceedsFromSaleOfUnderwritersReimbursement>
    <ccxi:DeferredUnderwritingFee
      contextRef="cref_598338636"
      decimals="0"
      id="ixv-4102"
      unitRef="uref_1046053354">15990000</ccxi:DeferredUnderwritingFee>
    <ccxi:OtherOfferingCosts
      contextRef="cref_598338636"
      decimals="0"
      id="ixv-4103"
      unitRef="uref_1046053354">628232</ccxi:OtherOfferingCosts>
    <us-gaap:ProceedsFromIssuanceInitialPublicOffering
      contextRef="cref_528632504"
      decimals="0"
      id="ixv-4104"
      unitRef="uref_1046053354">414000000</us-gaap:ProceedsFromIssuanceInitialPublicOffering>
    <us-gaap:SharesIssuedPricePerShare
      contextRef="cref_1387385282"
      decimals="2"
      id="ixv-4105"
      unitRef="uref_123589252">10</us-gaap:SharesIssuedPricePerShare>
    <ccxi:NoOfMaturityDays contextRef="cref_528632504" id="ixv-4106">P185D</ccxi:NoOfMaturityDays>
    <ccxi:InitialBusinessCombinationOrToRedeemPercentage
      contextRef="cref_598338636"
      decimals="2"
      id="ixv-4107"
      unitRef="uref_2103209578">1</ccxi:InitialBusinessCombinationOrToRedeemPercentage>
    <ccxi:InitialBusinessCombinationOrToRedeemPercentage
      contextRef="cref_598338636"
      decimals="2"
      id="ixv-4108"
      unitRef="uref_2103209578">1</ccxi:InitialBusinessCombinationOrToRedeemPercentage>
    <ccxi:MinimumPercentageOfFairMarketValueOfBusinessAcquisitionToTrustAccountBalance
      contextRef="cref_598338636"
      decimals="2"
      id="ixv-4109"
      unitRef="uref_2103209578">0.80</ccxi:MinimumPercentageOfFairMarketValueOfBusinessAcquisitionToTrustAccountBalance>
    <ccxi:AdvanceReceivedForWorkingCapital
      contextRef="cref_598338636"
      decimals="0"
      id="ixv-4110"
      unitRef="uref_1046053354">1000000</ccxi:AdvanceReceivedForWorkingCapital>
    <ccxi:MaximumNetInterestToPayDissolutionExpenses
      contextRef="cref_964743498"
      decimals="0"
      id="ixv-4111"
      unitRef="uref_1046053354">100000</ccxi:MaximumNetInterestToPayDissolutionExpenses>
    <us-gaap:Cash
      contextRef="cref_886637457"
      decimals="0"
      id="ixv-4112"
      unitRef="uref_1046053354">410097</us-gaap:Cash>
    <ccxi:WorkingCapitalDeficit
      contextRef="cref_886637457"
      decimals="0"
      id="ixv-4113"
      unitRef="uref_1046053354">635351</ccxi:WorkingCapitalDeficit>
    <ccxi:WorkingCapitalLoan
      contextRef="cref_964743498"
      decimals="0"
      id="ixv-4114"
      unitRef="uref_1046053354">1500000</ccxi:WorkingCapitalLoan>
    <us-gaap:SaleOfStockPricePerShare
      contextRef="cref_886637457"
      decimals="2"
      id="ixv-4115"
      unitRef="uref_123589252">10</us-gaap:SaleOfStockPricePerShare>
    <ccxi:MaximumNetInterestToPayDissolutionExpenses
      contextRef="cref_886637457"
      decimals="0"
      id="ixv-4116"
      unitRef="uref_1046053354">1000000</ccxi:MaximumNetInterestToPayDissolutionExpenses>
    <ccxi:PermittedWithdraws
      contextRef="cref_1648036551"
      decimals="0"
      id="ixv-4117"
      unitRef="uref_1046053354">1000000</ccxi:PermittedWithdraws>
    <us-gaap:SignificantAccountingPoliciesTextBlock contextRef="cref_598338636" id="ixv-1934">&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-weight: bold;"&gt;Note&#160;2&#160;&#x2014;&#160;Summary of Significant Accounting Policies&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-weight: bold;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-weight: bold;"&gt;&lt;i&gt;Basis of Presentation&lt;/i&gt;&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;The accompanying unaudited condensed financial statements have been prepared in accordance with accounting principles generally accepted in the United States of America (&#x201c;GAAP&#x201d;) for interim financial information and in accordance with the instructions to Form 10-Q and Article 8 of Regulation S-X of the SEC. Certain information or footnote disclosures normally included in financial statements prepared in accordance with GAAP have been condensed or omitted, pursuant to the rules and regulations of the SEC for interim financial reporting. Accordingly, they do not include all the information and footnotes necessary for a complete presentation of financial position, results of operations, or cash flows. In the opinion of management, the accompanying unaudited condensed financial statements include all adjustments, consisting of a normal recurring nature, which are necessary for a fair presentation of the financial position, operating results and cash flows for the periods presented.&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-weight: bold;"&gt;&lt;i&gt;&#160;&lt;/i&gt;&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;The accompanying unaudited condensed financial statements should be read in conjunction with the Company&#x2019;s Annual Report on Form 10-K as of and for the period ended December 31, 2025, as filed with the SEC on March 26, 2026. The interim results for the three months ended March 31, 2026 are not necessarily indicative of the results to be expected for the year ending December 31, 2026 or for any future periods.&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;span style="font-weight: bold;"&gt;&lt;i&gt;Emerging Growth Company Status&lt;/i&gt;&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 29.15pt; text-indent: 17.45pt"&gt;&#160;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;As an &#x201c;emerging growth company,&#x201d; as defined in Section&#160;2(a)&#160;of the Securities Act, as modified by the JOBS Act, the Company may take advantage of certain exemptions from various reporting requirements that are applicable to other public companies that are not emerging growth companies including, but not limited to, not being required to comply with the auditor attestation requirements of Section&#160;404 of the Sarbanes-Oxley Act, as amended, reduced disclosure obligations regarding executive compensation in its periodic reports and proxy statements, and exemptions from the requirements of holding a non-binding advisory vote on executive compensation and shareholder approval of any golden parachute payments not previously approved.&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 29.15pt; text-indent: 17.45pt"&gt;&#160;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;Section&#160;102(b)(1)&#160;of the JOBS Act exempts emerging growth companies from being required to comply with new or revised financial accounting standards until private companies (that is, those that have not had a Securities Act registration statement declared effective or do not have a class of securities registered under the Securities Exchange&#160;Act of 1934, as amended) are required to comply with the new or revised financial accounting standards. The JOBS Act provides that a company can elect to opt out of the extended transition period and comply with the requirements that apply to non-emerging growth companies but any such election to opt out is irrevocable. The Company has elected not to opt out of such extended transition period which means that when a standard is issued or revised and it has different application dates for public or private companies, the Company, as an emerging growth company, can adopt the new or revised standard at the time private companies adopt the new or revised standard. This may make comparison of the Company&#x2019;s unaudited condensed financial statement with another public company which is neither an emerging growth company nor an emerging growth company that has opted out of using the extended transition period difficult or impossible because of the potential differences in accounting standards used.&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 29.15pt"&gt;&lt;span style="font-weight: bold;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;span style="font-weight: bold;"&gt;&lt;i&gt;Cash and Cash Equivalents&lt;/i&gt;&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 29.15pt; text-indent: 17.45pt"&gt;&lt;i&gt;&#160;&lt;/i&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt; The Company considers all short-term investments with an original maturity of three months or less when purchased to be cash equivalents. The Company had cash of $410,097 and $736,204 as of March 31, 2026 and December 31, 2025, respectively, and did &lt;span style="-sec-ix-hidden:fc_1896867140"&gt;not&lt;/span&gt; have any cash equivalents. &lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-weight: bold;"&gt;&lt;i&gt;Marketable Securities Held in Trust Account&lt;/i&gt;&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt; The Company classifies its U.S. Treasury and equivalent securities as held-to-maturity in accordance with ASC Topic 320, &#x201c;Investments - Debt and Equity Securities.&#x201d; Held-to-maturity securities are those securities which the Company has the ability and intent to hold until maturity. Held-to-maturity treasury securities are recorded at amortized cost on the accompanying condensed balance sheets and adjusted for the amortization or accretion of premiums or discounts. At March 31, 2026, $418,017,967 was invested in U.S. Treasury Securities at an amortized cost of $418,094,829 and $676 was held in cash, for a total of $418,094,829 as reflected on the accompanying condensed balance sheets (see Note 9). At December 31, 2025, $414,429,619 was invested in U.S. Treasury Securities at an amortized cost of $414,549,783 and $676 was held in cash, for a total of $414,549,783 as reflected on the accompanying condensed balance sheets (see Note 9). &lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt; To fund working capital, the Company has permitted withdrawals available up to an annual limit of $1,000,000. These permitted withdrawals are limited to only the interest available that has been earned in excess of the initial deposit at the Initial Public Offering. For the three months ended March 31, 2026 and for the year ended December 31, 2025, the Company did not withdraw any amounts from the Trust Account for working capital purposes. As of March 31, 2026, the Company had $1,000,000 available for permitted withdrawals for the period from December 18, 2025 until December 18, 2026, which is the 1-year anniversary of the Initial Public Offering. &lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;span style="font-weight: bold;"&gt;&lt;i&gt;Concentration of Credit Risk&lt;/i&gt;&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 29.15pt; text-indent: 17.45pt"&gt;&#160;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt; Financial instruments that potentially subject the Company to concentrations of credit risk consist of a cash account in a financial institution, which, at times, may exceed the Federal Deposit Insurance Corporation coverage limit of $250,000. Any loss incurred or a lack of access to such funds could have a significant adverse impact on the Company&#x2019;s financial condition, results of operations, and cash flows. &lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;span style="font-weight: bold;"&gt;&lt;i&gt;Offering Costs&lt;/i&gt;&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 29.15pt; text-indent: 17.45pt"&gt;&#160;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;The Company complies with the requirements of the ASC&#160;340-10-S99 and SEC Staff Accounting Bulletin (&#x201c;SAB&#x201d;) Topic&#160;5A&#160;&#x2014;&#160;&#x201c;Expenses of Offering.&#x201d; Deferred offering costs consist principally of professional and registration fees that are related to the Initial Public Offering. FASB ASC&#160;470-20, &#x201c;Debt with Conversion and Other Options,&#x201d; addresses the allocation of proceeds from the issuance of convertible debt into its equity and debt components. The Company applies this guidance to allocate Initial Public Offering proceeds from the Public Units&#160;between Class A Ordinary Shares and warrants, using the residual method by allocating Initial Public Offering proceeds first to assigned value of the warrants and then to the Class A Ordinary Shares. Offering costs allocated to the Class&#160;A Ordinary Shares subject to possible redemption will be charged to temporary equity, and offering costs allocated to the warrants included in the Public Units&#160;and Private Placement Units&#160;are charged to shareholders&#x2019; deficit as the warrants, after management&#x2019;s evaluation, are accounted for under equity treatment.&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt; Transaction costs amounted to $19,618,232, consisting of $3,000,000 of cash underwriting fees (net of $3,210,000 underwriter&#x2019;s reimbursement), $15,990,000 of deferred underwriting fees (the &#x201c;Deferred Fee&#x201d;) (Note 6), and $628,232 of other offering costs. &lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;span style="font-weight: bold;"&gt;&lt;i&gt;Financial Instruments&lt;/i&gt;&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 11.25pt; text-align: justify"&gt;&#160;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;The fair value of the Company&#x2019;s assets and liabilities, which qualify as financial instruments under the FASB ASC Topic 820, &#x201c;Fair Value Measurement,&#x201d; approximates the carrying amounts represented in the accompanying condensed balance sheets, primarily due to their short-term nature.&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;span style="font-weight: bold;"&gt;&lt;i&gt;Fair Value Measurements&lt;/i&gt;&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 11.25pt; text-align: justify"&gt;&#160;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;Fair value is defined as the price that would be received for sale of an asset or paid for transfer of a liability in an orderly transaction between market participants at the measurement date. GAAP establishes a three-tier fair value hierarchy, which prioritizes the inputs used in measuring fair value. The hierarchy gives the highest priority to unadjusted quoted prices in active markets for identical assets or liabilities (Level 1 measurements) and the lowest priority to unobservable inputs (Level 3 measurements). These tiers include:&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 11.25pt; text-align: justify"&gt;&#160;&lt;/p&gt;&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"&gt;&lt;tbody&gt;&lt;tr style="vertical-align: top; text-align: justify"&gt;&lt;td style="width: 0.5in"&gt;&lt;/td&gt; &lt;td style="width: 0.25in; text-align: left"&gt;&lt;span style="font-size: 10pt"&gt;&#x25cf;&lt;/span&gt;&lt;/td&gt; &lt;td style="text-align: justify"&gt;&lt;span style="font-size: 10pt"&gt;Level&#160;1, defined as observable inputs such as quoted prices (unadjusted) for identical instruments in active markets;&lt;/span&gt;&lt;/td&gt; &lt;/tr&gt;&lt;/tbody&gt;&lt;/table&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 11.25pt; text-align: justify"&gt;&#160;&lt;/p&gt;&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"&gt;&lt;tbody&gt;&lt;tr style="vertical-align: top; text-align: justify"&gt;&lt;td style="width: 0.5in"&gt;&lt;/td&gt; &lt;td style="width: 0.25in; text-align: left"&gt;&lt;span style="font-size: 10pt"&gt;&#x25cf;&lt;/span&gt;&lt;/td&gt; &lt;td style="text-align: justify"&gt;&lt;span style="font-size: 10pt"&gt;Level&#160;2, defined as inputs other than quoted prices in active markets that are either directly or indirectly observable such as quoted prices for similar instruments in active markets or quoted prices for identical or similar instruments in markets that are not active; and&lt;/span&gt;&lt;/td&gt; &lt;/tr&gt;&lt;/tbody&gt;&lt;/table&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 11.25pt; text-align: justify"&gt;&#160;&lt;/p&gt;&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"&gt;&lt;tbody&gt;&lt;tr style="vertical-align: top; text-align: justify"&gt;&lt;td style="width: 0.5in"&gt;&lt;/td&gt; &lt;td style="width: 0.25in; text-align: left"&gt;&lt;span style="font-size: 10pt"&gt;&#x25cf;&lt;/span&gt;&lt;/td&gt; &lt;td style="text-align: justify"&gt;&lt;span style="font-size: 10pt"&gt;Level&#160;3, defined as unobservable inputs in which little or no market data exists, therefore requiring an entity to develop its own assumptions, such as valuations derived from valuation techniques in which one or more significant inputs or significant value drivers are unobservable. In some circumstances, the inputs used to measure fair value might be categorized within different levels of the fair value hierarchy. In those instances, the fair value measurement is categorized in its entirety in the fair value hierarchy based on the lowest level input that is significant to the fair value measurement.&lt;/span&gt;&lt;/td&gt; &lt;/tr&gt;&lt;/tbody&gt;&lt;/table&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;span style="font-weight: bold;"&gt;&lt;i&gt;Use of Estimates&lt;/i&gt;&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 11.25pt; text-align: justify"&gt;&#160;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;The preparation of the accompanying unaudited condensed financial statements in conformity with GAAP requires the Company&#x2019;s management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the accompanying unaudited condensed financial statements and the reported amounts of expenses during the reporting period.&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 11.25pt; text-align: justify"&gt;&#160;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;Making estimates requires management to exercise significant judgement. It is at least reasonably possible that the estimate of the effect of a condition, situation or set of circumstances that existed at the date of the accompanying unaudited condensed financial statements, which management considered in formulating its estimate, could change in the near term due to one or more future confirming events. Accordingly, the actual results could differ significantly from those estimates.&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-weight: bold;"&gt;&lt;i&gt;Net Income Per Ordinary Share&lt;/i&gt;&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;span style="font-weight: bold;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;The Company complies with accounting and disclosure requirements of FASB ASC Topic 260, &#x201c;Earnings Per Share.&#x201d; Income and losses are shared pro rata to the shares. Net income per Ordinary Share is computed by dividing net income by the weighted average number of Ordinary Shares outstanding for the period. Accretion associated with the redeemable Ordinary Shares is excluded from income per Ordinary Share as the redemption value approximates fair value.&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt; The calculation of diluted income per Ordinary Share does not consider the effect of the Warrants issued in connection with the (i) Initial Public Offering, (ii) the exercise of the Over-Allotment Option and (iii) Private Placement, since the average price of the Ordinary Shares for the three months ended March 31, 2026, was less than the exercise price and therefore, the inclusion of such Warrants under the Treasury stock method would be anti-dilutive and the exercise is contingent upon the occurrence of future events. The Warrants are exercisable to purchase 4,190,000 Class A Ordinary Shares in the aggregate. As a result, diluted net income per Ordinary Share is the same as basic net income per Ordinary Share for the period presented. &lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;The following table reflects the calculation of basic and diluted net income per Ordinary Share (in dollars, except per share amounts):&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 16.2pt"&gt;&#160;&lt;/p&gt;&lt;table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif"&gt; &lt;tbody&gt;&lt;tr style="vertical-align: bottom"&gt;&lt;td&gt;&#160;&lt;/td&gt; &lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt; &lt;td colspan="6" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"&gt;For the Three Months Ended March 31, 2026&lt;/td&gt; &lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;&lt;tr style="vertical-align: bottom"&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;Basic and diluted net income per Ordinary Share&lt;/td&gt; &lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt; &lt;td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"&gt;Class&#160;A&lt;/td&gt; &lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt; &lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt; &lt;td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"&gt;Class&#160;B&lt;/td&gt; &lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;&lt;tr style="vertical-align: bottom"&gt;&lt;td&gt;Basic and diluted net income per Ordinary Share&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td colspan="2"&gt;&#160;&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td colspan="2"&gt;&#160;&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;/tr&gt;&lt;tr style="vertical-align: bottom"&gt;&lt;td&gt;Numerator:&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td colspan="2"&gt;&#160;&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td colspan="2"&gt;&#160;&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;/tr&gt;&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;&lt;td style="width: 76%; text-align: left; padding-left: 8.1pt"&gt;Allocation of net income&lt;/td&gt; &lt;td style="width: 1%"&gt;&#160;&lt;/td&gt; &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt; &lt;td style="width: 9%; text-align: right"&gt;2,385,647&lt;/td&gt; &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt; &lt;td style="width: 1%"&gt;&#160;&lt;/td&gt; &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt; &lt;td style="width: 9%; text-align: right"&gt;785,726&lt;/td&gt; &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;&lt;tr style="vertical-align: bottom; background-color: White"&gt;&lt;td&gt;Denominator:&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt; &lt;td style="text-align: right"&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt; &lt;td style="text-align: right"&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;&lt;td style="padding-bottom: 1.5pt; padding-left: 8.1pt"&gt;Basic and diluted weighted average shares outstanding&lt;/td&gt; &lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt; &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt; &lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;41,900,000&lt;/td&gt; &lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt; &lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt; &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt; &lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;13,800,000&lt;/td&gt; &lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;&lt;tr style="vertical-align: bottom; background-color: White"&gt;&lt;td style="text-align: left; padding-bottom: 2.5pt"&gt;Basic and diluted net income per Ordinary Share&lt;/td&gt; &lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt; &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;$&lt;/td&gt; &lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;0.06&lt;/td&gt; &lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt; &lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt; &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;$&lt;/td&gt; &lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;0.06&lt;/td&gt; &lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;&lt;/tbody&gt;&lt;/table&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;span style="font-weight: bold;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;span style="font-weight: bold;"&gt;&lt;i&gt;Income Taxes&lt;/i&gt;&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 29.15pt; text-indent: 17.45pt"&gt;&#160;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;The Company accounts for income taxes under FASB ASC Topic&#160;740, &#x201c;Income Taxes,&#x201d; (&#x201c;ASC Topic 740&#x201d;) which requires an asset and liability approach to financial accounting and reporting for income taxes. Deferred income tax assets and liabilities are computed for differences between the financial statement and tax bases of assets and liabilities that will result in future taxable or deductible amounts, based on enacted tax laws and rates applicable to the periods in which the differences are expected to affect taxable income. Valuation allowances are established, when necessary, to reduce deferred tax assets to the amount expected to be realized.&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 29.15pt; text-indent: 17.45pt"&gt;&#160;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt; ASC Topic&#160;740 prescribes a recognition threshold and a measurement attribute for the financial statement recognition and measurement of tax positions taken or expected to be taken in a tax return. For those benefits to be recognized, a tax position must be more likely than not to be sustained upon examination by taxing authorities. The Company&#x2019;s management determined that the Cayman Islands is the Company&#x2019;s major tax jurisdiction. The Company recognizes accrued interest and penalties related to unrecognized tax benefits as income tax expense. As of March 31, 2026 and December 31, 2025, there were &lt;span style="-sec-ix-hidden:fc_495639681"&gt;no&lt;/span&gt; unrecognized tax benefits and &lt;span style="-sec-ix-hidden:fc_680601104"&gt;no&lt;/span&gt; amounts accrued for interest and penalties. The Company is currently not aware of any issues under review that could result in significant payments, accruals or material deviation from its position. &lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 29.15pt"&gt;&#160;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;The Company is considered to be an exempted Cayman Islands company with no connection to any other taxable jurisdiction and is presently not subject to income taxes or income tax filing requirements in the Cayman Islands or the United&#160;States. As such, the Company&#x2019;s tax provision was zero for the period presented.&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;span style="font-weight: bold;"&gt;&lt;i&gt;Class A Ordinary Shares Subject to Possible Redemption&lt;/i&gt;&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 29.15pt; text-indent: 17.45pt"&gt;&#160;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt; The Public Shares contain a redemption feature which allows for the redemption of such Public Shares in connection with the Company&#x2019;s liquidation, if there is a shareholder vote (A) to modify the substance or timing of the Company&#x2019;s obligation to allow redemption in connection with a Business Combination or to redeem 100% of the Public Shares if the Company does not complete an initial Business Combination within the completion window or (B) with respect to any other material provisions relating to shareholders&#x2019; rights or pre-initial Business Combination activity, or if there is a shareholder vote or tender offer in connection with the Company&#x2019;s initial Business Combination. In accordance with ASC 480-10-S99, the Company classifies Public Shares subject to redemption outside of permanent equity as the redemption provisions are not solely within the control of the Company. The Company recognizes changes in redemption value immediately as they occur and will adjust the carrying value of redeemable shares to equal the redemption value at the end of each reporting period. Immediately upon the closing of the Initial Public Offering, the Company recognized the accretion from initial book value to redemption value. The change in the carrying value of redeemable shares will result in charges against additional paid-in capital (to the extent available) and accumulated deficit. Accordingly, as of March 31, 2026 and December 31, 2025, Class A Ordinary Shares subject to possible redemption are presented at redemption value as temporary equity, outside of the shareholders&#x2019; deficit section of the Company&#x2019;s condensed balance sheets. As of March 31, 2026 and December 31, 2025, the Class A Ordinary Shares subject to possible redemption reflected in the condensed balance sheets are reconciled in the following table: &lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 39.25pt; text-indent: 17.8pt"&gt;&#160;&lt;/p&gt;&lt;table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif"&gt; &lt;tbody&gt;&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;&lt;td style="width: 88%; text-align: left"&gt;Gross proceeds&lt;/td&gt; &lt;td style="width: 1%"&gt;&#160;&lt;/td&gt; &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt; &lt;td style="width: 9%; text-align: right"&gt;414,000,000&lt;/td&gt; &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;&lt;tr style="vertical-align: bottom; background-color: White"&gt;&lt;td&gt;Less:&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt; &lt;td style="text-align: right"&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;&lt;td style="text-align: left"&gt;Proceeds allocated to Public Warrants&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt; &lt;td style="text-align: right"&gt;(2,028,600&lt;/td&gt; &lt;td style="text-align: left"&gt;)&lt;/td&gt; &lt;/tr&gt;&lt;tr style="vertical-align: bottom; background-color: White"&gt;&lt;td style="text-align: left"&gt;Public Shares issuance costs&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt; &lt;td style="text-align: right"&gt;(19,514,643&lt;/td&gt; &lt;td style="text-align: left"&gt;)&lt;/td&gt; &lt;/tr&gt;&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;&lt;td&gt;Plus:&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt; &lt;td style="text-align: right"&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;&lt;tr style="vertical-align: bottom; background-color: White"&gt;&lt;td style="padding-bottom: 1.5pt"&gt;Accretion of carrying value to redemption value&lt;/td&gt; &lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt; &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt; &lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;21,543,243&lt;/td&gt; &lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;&lt;td style="text-align: left"&gt;Class A Ordinary Shares subject to possible redemption, December 31, 2025&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt; &lt;td style="text-align: right"&gt;414,000,000&lt;/td&gt; &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;&lt;tr style="vertical-align: bottom; background-color: White"&gt;&lt;td&gt;Plus:&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt; &lt;td style="text-align: right"&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;&lt;td style="padding-bottom: 1.5pt"&gt;Accretion of carrying value to redemption value&lt;/td&gt; &lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt; &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt; &lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;3,094,829&lt;/td&gt; &lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;&lt;tr style="vertical-align: bottom; background-color: White"&gt;&lt;td style="text-align: left; padding-bottom: 2.5pt"&gt;Class A Ordinary Shares subject to possible redemption, March 31, 2026&lt;/td&gt; &lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt; &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;$&lt;/td&gt; &lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;417,094,829&lt;/td&gt; &lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;&lt;/tbody&gt;&lt;/table&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;span style="font-weight: bold;"&gt;&lt;i&gt;Warrant Instruments&lt;/i&gt;&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 29.15pt; text-indent: 17.45pt"&gt;&#160;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt; The Company accounts for the Public and Private Warrants to be issued in connection with the Initial Public Offering and the private placement in accordance with the guidance contained in FASB ASC Topic&#160;815, &#x201c;Derivatives and Hedging.&#x201d; Accordingly, the Company evaluated and classified the warrant instruments under equity treatment at their assigned value. There are 4,140,000 Public Warrants (as defined in Note 1) and 50,000 Private Warrants (as defined in Note 4) currently outstanding as of March 31, 2026 and December 31, 2025. &lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;span style="font-weight: bold;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;span style="font-weight: bold;"&gt;&lt;i&gt;Recent Accounting Pronouncements&lt;/i&gt;&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 29.15pt; text-indent: 17.45pt"&gt;&#160;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;Management does not believe that any recently issued, but not effective, accounting standards, if currently adopted, would have a material effect on the Company&#x2019;s unaudited condensed financial statements.&lt;/p&gt;</us-gaap:SignificantAccountingPoliciesTextBlock>
    <us-gaap:BasisOfAccountingPolicyPolicyTextBlock contextRef="cref_598338636" id="ixv-1939">&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-weight: bold;"&gt;&lt;i&gt;Basis of Presentation&lt;/i&gt;&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;The accompanying unaudited condensed financial statements have been prepared in accordance with accounting principles generally accepted in the United States of America (&#x201c;GAAP&#x201d;) for interim financial information and in accordance with the instructions to Form 10-Q and Article 8 of Regulation S-X of the SEC. Certain information or footnote disclosures normally included in financial statements prepared in accordance with GAAP have been condensed or omitted, pursuant to the rules and regulations of the SEC for interim financial reporting. Accordingly, they do not include all the information and footnotes necessary for a complete presentation of financial position, results of operations, or cash flows. In the opinion of management, the accompanying unaudited condensed financial statements include all adjustments, consisting of a normal recurring nature, which are necessary for a fair presentation of the financial position, operating results and cash flows for the periods presented.&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-weight: bold;"&gt;&lt;i&gt;&#160;&lt;/i&gt;&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;The accompanying unaudited condensed financial statements should be read in conjunction with the Company&#x2019;s Annual Report on Form 10-K as of and for the period ended December 31, 2025, as filed with the SEC on March 26, 2026. The interim results for the three months ended March 31, 2026 are not necessarily indicative of the results to be expected for the year ending December 31, 2026 or for any future periods.&lt;/p&gt;</us-gaap:BasisOfAccountingPolicyPolicyTextBlock>
    <ccxi:EmergingGrowthCompanyStatusPolicyTextBlock contextRef="cref_598338636" id="ixv-1950">&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;span style="font-weight: bold;"&gt;&lt;i&gt;Emerging Growth Company Status&lt;/i&gt;&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 29.15pt; text-indent: 17.45pt"&gt;&#160;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;As an &#x201c;emerging growth company,&#x201d; as defined in Section&#160;2(a)&#160;of the Securities Act, as modified by the JOBS Act, the Company may take advantage of certain exemptions from various reporting requirements that are applicable to other public companies that are not emerging growth companies including, but not limited to, not being required to comply with the auditor attestation requirements of Section&#160;404 of the Sarbanes-Oxley Act, as amended, reduced disclosure obligations regarding executive compensation in its periodic reports and proxy statements, and exemptions from the requirements of holding a non-binding advisory vote on executive compensation and shareholder approval of any golden parachute payments not previously approved.&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 29.15pt; text-indent: 17.45pt"&gt;&#160;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;Section&#160;102(b)(1)&#160;of the JOBS Act exempts emerging growth companies from being required to comply with new or revised financial accounting standards until private companies (that is, those that have not had a Securities Act registration statement declared effective or do not have a class of securities registered under the Securities Exchange&#160;Act of 1934, as amended) are required to comply with the new or revised financial accounting standards. The JOBS Act provides that a company can elect to opt out of the extended transition period and comply with the requirements that apply to non-emerging growth companies but any such election to opt out is irrevocable. The Company has elected not to opt out of such extended transition period which means that when a standard is issued or revised and it has different application dates for public or private companies, the Company, as an emerging growth company, can adopt the new or revised standard at the time private companies adopt the new or revised standard. This may make comparison of the Company&#x2019;s unaudited condensed financial statement with another public company which is neither an emerging growth company nor an emerging growth company that has opted out of using the extended transition period difficult or impossible because of the potential differences in accounting standards used.&lt;/p&gt;</ccxi:EmergingGrowthCompanyStatusPolicyTextBlock>
    <us-gaap:CashAndCashEquivalentsPolicyTextBlock contextRef="cref_598338636" id="ixv-1960">&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;span style="font-weight: bold;"&gt;&lt;i&gt;Cash and Cash Equivalents&lt;/i&gt;&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 29.15pt; text-indent: 17.45pt"&gt;&lt;i&gt;&#160;&lt;/i&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt; The Company considers all short-term investments with an original maturity of three months or less when purchased to be cash equivalents. The Company had cash of $410,097 and $736,204 as of March 31, 2026 and December 31, 2025, respectively, and did &lt;span style="-sec-ix-hidden:fc_1896867140"&gt;not&lt;/span&gt; have any cash equivalents. &lt;/p&gt;</us-gaap:CashAndCashEquivalentsPolicyTextBlock>
    <us-gaap:Cash
      contextRef="cref_886637457"
      decimals="0"
      id="ixv-4118"
      unitRef="uref_1046053354">410097</us-gaap:Cash>
    <us-gaap:Cash
      contextRef="cref_294760605"
      decimals="0"
      id="ixv-4119"
      unitRef="uref_1046053354">736204</us-gaap:Cash>
    <ccxi:MarketableSecuritiesHeldInTrustAccountPolicyTextBlock contextRef="cref_598338636" id="ixv-1976">&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-weight: bold;"&gt;&lt;i&gt;Marketable Securities Held in Trust Account&lt;/i&gt;&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt; The Company classifies its U.S. Treasury and equivalent securities as held-to-maturity in accordance with ASC Topic 320, &#x201c;Investments - Debt and Equity Securities.&#x201d; Held-to-maturity securities are those securities which the Company has the ability and intent to hold until maturity. Held-to-maturity treasury securities are recorded at amortized cost on the accompanying condensed balance sheets and adjusted for the amortization or accretion of premiums or discounts. At March 31, 2026, $418,017,967 was invested in U.S. Treasury Securities at an amortized cost of $418,094,829 and $676 was held in cash, for a total of $418,094,829 as reflected on the accompanying condensed balance sheets (see Note 9). At December 31, 2025, $414,429,619 was invested in U.S. Treasury Securities at an amortized cost of $414,549,783 and $676 was held in cash, for a total of $414,549,783 as reflected on the accompanying condensed balance sheets (see Note 9). &lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt; To fund working capital, the Company has permitted withdrawals available up to an annual limit of $1,000,000. These permitted withdrawals are limited to only the interest available that has been earned in excess of the initial deposit at the Initial Public Offering. For the three months ended March 31, 2026 and for the year ended December 31, 2025, the Company did not withdraw any amounts from the Trust Account for working capital purposes. As of March 31, 2026, the Company had $1,000,000 available for permitted withdrawals for the period from December 18, 2025 until December 18, 2026, which is the 1-year anniversary of the Initial Public Offering. &lt;/p&gt;</ccxi:MarketableSecuritiesHeldInTrustAccountPolicyTextBlock>
    <us-gaap:AssetsHeldInTrust
      contextRef="cref_886637457"
      decimals="0"
      id="ixv-4120"
      unitRef="uref_1046053354">418017967</us-gaap:AssetsHeldInTrust>
    <us-gaap:AssetsHeldInTrustNoncurrent
      contextRef="cref_1953307244"
      decimals="0"
      id="ixv-4121"
      unitRef="uref_1046053354">418094829</us-gaap:AssetsHeldInTrustNoncurrent>
    <us-gaap:Cash
      contextRef="cref_1953307244"
      decimals="0"
      id="ixv-4122"
      unitRef="uref_1046053354">676</us-gaap:Cash>
    <us-gaap:AssetsHeldInTrustNoncurrent
      contextRef="cref_886637457"
      decimals="0"
      id="ixv-4123"
      unitRef="uref_1046053354">418094829</us-gaap:AssetsHeldInTrustNoncurrent>
    <us-gaap:AssetsHeldInTrust
      contextRef="cref_2146114570"
      decimals="0"
      id="ixv-4124"
      unitRef="uref_1046053354">414429619</us-gaap:AssetsHeldInTrust>
    <us-gaap:AssetsHeldInTrust
      contextRef="cref_294760605"
      decimals="0"
      id="ixv-4125"
      unitRef="uref_1046053354">414549783</us-gaap:AssetsHeldInTrust>
    <us-gaap:Cash
      contextRef="cref_2146114570"
      decimals="0"
      id="ixv-4126"
      unitRef="uref_1046053354">676</us-gaap:Cash>
    <us-gaap:AssetsHeldInTrustNoncurrent
      contextRef="cref_294760605"
      decimals="0"
      id="ixv-4127"
      unitRef="uref_1046053354">414549783</us-gaap:AssetsHeldInTrustNoncurrent>
    <ccxi:WorkingCapitalWithdrawal
      contextRef="cref_886637457"
      decimals="0"
      id="ixv-4128"
      unitRef="uref_1046053354">1000000</ccxi:WorkingCapitalWithdrawal>
    <ccxi:WorkingCapitalWithdrawal
      contextRef="cref_1648036551"
      decimals="0"
      id="ixv-4129"
      unitRef="uref_1046053354">1000000</ccxi:WorkingCapitalWithdrawal>
    <us-gaap:ConcentrationRiskCreditRisk contextRef="cref_598338636" id="ixv-1985">&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;span style="font-weight: bold;"&gt;&lt;i&gt;Concentration of Credit Risk&lt;/i&gt;&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 29.15pt; text-indent: 17.45pt"&gt;&#160;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt; Financial instruments that potentially subject the Company to concentrations of credit risk consist of a cash account in a financial institution, which, at times, may exceed the Federal Deposit Insurance Corporation coverage limit of $250,000. Any loss incurred or a lack of access to such funds could have a significant adverse impact on the Company&#x2019;s financial condition, results of operations, and cash flows. &lt;/p&gt;</us-gaap:ConcentrationRiskCreditRisk>
    <us-gaap:CashFDICInsuredAmount
      contextRef="cref_886637457"
      decimals="0"
      id="ixv-4130"
      unitRef="uref_1046053354">250000</us-gaap:CashFDICInsuredAmount>
    <ccxi:OfferingCostsPolicyTextBlock contextRef="cref_598338636" id="ixv-1992">&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;span style="font-weight: bold;"&gt;&lt;i&gt;Offering Costs&lt;/i&gt;&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 29.15pt; text-indent: 17.45pt"&gt;&#160;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;The Company complies with the requirements of the ASC&#160;340-10-S99 and SEC Staff Accounting Bulletin (&#x201c;SAB&#x201d;) Topic&#160;5A&#160;&#x2014;&#160;&#x201c;Expenses of Offering.&#x201d; Deferred offering costs consist principally of professional and registration fees that are related to the Initial Public Offering. FASB ASC&#160;470-20, &#x201c;Debt with Conversion and Other Options,&#x201d; addresses the allocation of proceeds from the issuance of convertible debt into its equity and debt components. The Company applies this guidance to allocate Initial Public Offering proceeds from the Public Units&#160;between Class A Ordinary Shares and warrants, using the residual method by allocating Initial Public Offering proceeds first to assigned value of the warrants and then to the Class A Ordinary Shares. Offering costs allocated to the Class&#160;A Ordinary Shares subject to possible redemption will be charged to temporary equity, and offering costs allocated to the warrants included in the Public Units&#160;and Private Placement Units&#160;are charged to shareholders&#x2019; deficit as the warrants, after management&#x2019;s evaluation, are accounted for under equity treatment.&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt; Transaction costs amounted to $19,618,232, consisting of $3,000,000 of cash underwriting fees (net of $3,210,000 underwriter&#x2019;s reimbursement), $15,990,000 of deferred underwriting fees (the &#x201c;Deferred Fee&#x201d;) (Note 6), and $628,232 of other offering costs. &lt;/p&gt;</ccxi:OfferingCostsPolicyTextBlock>
    <ccxi:TransactionCosts
      contextRef="cref_598338636"
      decimals="0"
      id="ixv-4131"
      unitRef="uref_1046053354">19618232</ccxi:TransactionCosts>
    <ccxi:CashUnderwritingFees
      contextRef="cref_598338636"
      decimals="0"
      id="ixv-4132"
      unitRef="uref_1046053354">3000000</ccxi:CashUnderwritingFees>
    <ccxi:ProceedsFromSaleOfUnderwritersReimbursement
      contextRef="cref_598338636"
      decimals="0"
      id="ixv-4133"
      unitRef="uref_1046053354">-3210000</ccxi:ProceedsFromSaleOfUnderwritersReimbursement>
    <ccxi:DeferredUnderwritingFeeNoncurrent
      contextRef="cref_886637457"
      decimals="0"
      id="ixv-4134"
      unitRef="uref_1046053354">15990000</ccxi:DeferredUnderwritingFeeNoncurrent>
    <ccxi:OtherOfferingCosts
      contextRef="cref_598338636"
      decimals="0"
      id="ixv-4135"
      unitRef="uref_1046053354">628232</ccxi:OtherOfferingCosts>
    <us-gaap:FairValueOfFinancialInstrumentsPolicy contextRef="cref_598338636" id="ixv-2001">&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;span style="font-weight: bold;"&gt;&lt;i&gt;Financial Instruments&lt;/i&gt;&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 11.25pt; text-align: justify"&gt;&#160;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;The fair value of the Company&#x2019;s assets and liabilities, which qualify as financial instruments under the FASB ASC Topic 820, &#x201c;Fair Value Measurement,&#x201d; approximates the carrying amounts represented in the accompanying condensed balance sheets, primarily due to their short-term nature.&lt;/p&gt;</us-gaap:FairValueOfFinancialInstrumentsPolicy>
    <us-gaap:FairValueMeasurementPolicyPolicyTextBlock contextRef="cref_598338636" id="ixv-2015">&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;span style="font-weight: bold;"&gt;&lt;i&gt;Fair Value Measurements&lt;/i&gt;&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 11.25pt; text-align: justify"&gt;&#160;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;Fair value is defined as the price that would be received for sale of an asset or paid for transfer of a liability in an orderly transaction between market participants at the measurement date. GAAP establishes a three-tier fair value hierarchy, which prioritizes the inputs used in measuring fair value. The hierarchy gives the highest priority to unadjusted quoted prices in active markets for identical assets or liabilities (Level 1 measurements) and the lowest priority to unobservable inputs (Level 3 measurements). These tiers include:&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 11.25pt; text-align: justify"&gt;&#160;&lt;/p&gt;&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"&gt;&lt;tbody&gt;&lt;tr style="vertical-align: top; text-align: justify"&gt;&lt;td style="width: 0.5in"&gt;&lt;/td&gt; &lt;td style="width: 0.25in; text-align: left"&gt;&lt;span style="font-size: 10pt"&gt;&#x25cf;&lt;/span&gt;&lt;/td&gt; &lt;td style="text-align: justify"&gt;&lt;span style="font-size: 10pt"&gt;Level&#160;1, defined as observable inputs such as quoted prices (unadjusted) for identical instruments in active markets;&lt;/span&gt;&lt;/td&gt; &lt;/tr&gt;&lt;/tbody&gt;&lt;/table&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 11.25pt; text-align: justify"&gt;&#160;&lt;/p&gt;&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"&gt;&lt;tbody&gt;&lt;tr style="vertical-align: top; text-align: justify"&gt;&lt;td style="width: 0.5in"&gt;&lt;/td&gt; &lt;td style="width: 0.25in; text-align: left"&gt;&lt;span style="font-size: 10pt"&gt;&#x25cf;&lt;/span&gt;&lt;/td&gt; &lt;td style="text-align: justify"&gt;&lt;span style="font-size: 10pt"&gt;Level&#160;2, defined as inputs other than quoted prices in active markets that are either directly or indirectly observable such as quoted prices for similar instruments in active markets or quoted prices for identical or similar instruments in markets that are not active; and&lt;/span&gt;&lt;/td&gt; &lt;/tr&gt;&lt;/tbody&gt;&lt;/table&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 11.25pt; text-align: justify"&gt;&#160;&lt;/p&gt;&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"&gt;&lt;tbody&gt;&lt;tr style="vertical-align: top; text-align: justify"&gt;&lt;td style="width: 0.5in"&gt;&lt;/td&gt; &lt;td style="width: 0.25in; text-align: left"&gt;&lt;span style="font-size: 10pt"&gt;&#x25cf;&lt;/span&gt;&lt;/td&gt; &lt;td style="text-align: justify"&gt;&lt;span style="font-size: 10pt"&gt;Level&#160;3, defined as unobservable inputs in which little or no market data exists, therefore requiring an entity to develop its own assumptions, such as valuations derived from valuation techniques in which one or more significant inputs or significant value drivers are unobservable. In some circumstances, the inputs used to measure fair value might be categorized within different levels of the fair value hierarchy. In those instances, the fair value measurement is categorized in its entirety in the fair value hierarchy based on the lowest level input that is significant to the fair value measurement.&lt;/span&gt;&lt;/td&gt; &lt;/tr&gt;&lt;/tbody&gt;&lt;/table&gt;</us-gaap:FairValueMeasurementPolicyPolicyTextBlock>
    <us-gaap:UseOfEstimates contextRef="cref_598338636" id="ixv-2049">&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;span style="font-weight: bold;"&gt;&lt;i&gt;Use of Estimates&lt;/i&gt;&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 11.25pt; text-align: justify"&gt;&#160;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;The preparation of the accompanying unaudited condensed financial statements in conformity with GAAP requires the Company&#x2019;s management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the accompanying unaudited condensed financial statements and the reported amounts of expenses during the reporting period.&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 11.25pt; text-align: justify"&gt;&#160;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;Making estimates requires management to exercise significant judgement. It is at least reasonably possible that the estimate of the effect of a condition, situation or set of circumstances that existed at the date of the accompanying unaudited condensed financial statements, which management considered in formulating its estimate, could change in the near term due to one or more future confirming events. Accordingly, the actual results could differ significantly from those estimates.&lt;/p&gt;</us-gaap:UseOfEstimates>
    <us-gaap:EarningsPerSharePolicyTextBlock contextRef="cref_598338636" id="ixv-2058">&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-weight: bold;"&gt;&lt;i&gt;Net Income Per Ordinary Share&lt;/i&gt;&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;span style="font-weight: bold;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;The Company complies with accounting and disclosure requirements of FASB ASC Topic 260, &#x201c;Earnings Per Share.&#x201d; Income and losses are shared pro rata to the shares. Net income per Ordinary Share is computed by dividing net income by the weighted average number of Ordinary Shares outstanding for the period. Accretion associated with the redeemable Ordinary Shares is excluded from income per Ordinary Share as the redemption value approximates fair value.&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt; The calculation of diluted income per Ordinary Share does not consider the effect of the Warrants issued in connection with the (i) Initial Public Offering, (ii) the exercise of the Over-Allotment Option and (iii) Private Placement, since the average price of the Ordinary Shares for the three months ended March 31, 2026, was less than the exercise price and therefore, the inclusion of such Warrants under the Treasury stock method would be anti-dilutive and the exercise is contingent upon the occurrence of future events. The Warrants are exercisable to purchase 4,190,000 Class A Ordinary Shares in the aggregate. As a result, diluted net income per Ordinary Share is the same as basic net income per Ordinary Share for the period presented. &lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;The following table reflects the calculation of basic and diluted net income per Ordinary Share (in dollars, except per share amounts):&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 16.2pt"&gt;&#160;&lt;/p&gt;&lt;table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif"&gt; &lt;tbody&gt;&lt;tr style="vertical-align: bottom"&gt;&lt;td&gt;&#160;&lt;/td&gt; &lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt; &lt;td colspan="6" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"&gt;For the Three Months Ended March 31, 2026&lt;/td&gt; &lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;&lt;tr style="vertical-align: bottom"&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;Basic and diluted net income per Ordinary Share&lt;/td&gt; &lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt; &lt;td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"&gt;Class&#160;A&lt;/td&gt; &lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt; &lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt; &lt;td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"&gt;Class&#160;B&lt;/td&gt; &lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;&lt;tr style="vertical-align: bottom"&gt;&lt;td&gt;Basic and diluted net income per Ordinary Share&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td colspan="2"&gt;&#160;&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td colspan="2"&gt;&#160;&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;/tr&gt;&lt;tr style="vertical-align: bottom"&gt;&lt;td&gt;Numerator:&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td colspan="2"&gt;&#160;&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td colspan="2"&gt;&#160;&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;/tr&gt;&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;&lt;td style="width: 76%; text-align: left; padding-left: 8.1pt"&gt;Allocation of net income&lt;/td&gt; &lt;td style="width: 1%"&gt;&#160;&lt;/td&gt; &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt; &lt;td style="width: 9%; text-align: right"&gt;2,385,647&lt;/td&gt; &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt; &lt;td style="width: 1%"&gt;&#160;&lt;/td&gt; &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt; &lt;td style="width: 9%; text-align: right"&gt;785,726&lt;/td&gt; &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;&lt;tr style="vertical-align: bottom; background-color: White"&gt;&lt;td&gt;Denominator:&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt; &lt;td style="text-align: right"&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt; &lt;td style="text-align: right"&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;&lt;td style="padding-bottom: 1.5pt; padding-left: 8.1pt"&gt;Basic and diluted weighted average shares outstanding&lt;/td&gt; &lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt; &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt; &lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;41,900,000&lt;/td&gt; &lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt; &lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt; &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt; &lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;13,800,000&lt;/td&gt; &lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;&lt;tr style="vertical-align: bottom; background-color: White"&gt;&lt;td style="text-align: left; padding-bottom: 2.5pt"&gt;Basic and diluted net income per Ordinary Share&lt;/td&gt; &lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt; &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;$&lt;/td&gt; &lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;0.06&lt;/td&gt; &lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt; &lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt; &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;$&lt;/td&gt; &lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;0.06&lt;/td&gt; &lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;&lt;/tbody&gt;&lt;/table&gt;</us-gaap:EarningsPerSharePolicyTextBlock>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="cref_1940557082"
      decimals="0"
      id="ixv-4136"
      unitRef="uref_1880167681">4190000</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock contextRef="cref_598338636" id="ixv-2075">&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;The following table reflects the calculation of basic and diluted net income per Ordinary Share (in dollars, except per share amounts):&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 16.2pt"&gt;&#160;&lt;/p&gt;&lt;table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif"&gt; &lt;tbody&gt;&lt;tr style="vertical-align: bottom"&gt;&lt;td&gt;&#160;&lt;/td&gt; &lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt; &lt;td colspan="6" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"&gt;For the Three Months Ended March 31, 2026&lt;/td&gt; &lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;&lt;tr style="vertical-align: bottom"&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;Basic and diluted net income per Ordinary Share&lt;/td&gt; &lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt; &lt;td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"&gt;Class&#160;A&lt;/td&gt; &lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt; &lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt; &lt;td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"&gt;Class&#160;B&lt;/td&gt; &lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;&lt;tr style="vertical-align: bottom"&gt;&lt;td&gt;Basic and diluted net income per Ordinary Share&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td colspan="2"&gt;&#160;&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td colspan="2"&gt;&#160;&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;/tr&gt;&lt;tr style="vertical-align: bottom"&gt;&lt;td&gt;Numerator:&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td colspan="2"&gt;&#160;&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td colspan="2"&gt;&#160;&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;/tr&gt;&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;&lt;td style="width: 76%; text-align: left; padding-left: 8.1pt"&gt;Allocation of net income&lt;/td&gt; &lt;td style="width: 1%"&gt;&#160;&lt;/td&gt; &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt; &lt;td style="width: 9%; text-align: right"&gt;2,385,647&lt;/td&gt; &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt; &lt;td style="width: 1%"&gt;&#160;&lt;/td&gt; &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt; &lt;td style="width: 9%; text-align: right"&gt;785,726&lt;/td&gt; &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;&lt;tr style="vertical-align: bottom; background-color: White"&gt;&lt;td&gt;Denominator:&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt; &lt;td style="text-align: right"&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt; &lt;td style="text-align: right"&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;&lt;td style="padding-bottom: 1.5pt; padding-left: 8.1pt"&gt;Basic and diluted weighted average shares outstanding&lt;/td&gt; &lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt; &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt; &lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;41,900,000&lt;/td&gt; &lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt; &lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt; &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt; &lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;13,800,000&lt;/td&gt; &lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;&lt;tr style="vertical-align: bottom; background-color: White"&gt;&lt;td style="text-align: left; padding-bottom: 2.5pt"&gt;Basic and diluted net income per Ordinary Share&lt;/td&gt; &lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt; &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;$&lt;/td&gt; &lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;0.06&lt;/td&gt; &lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt; &lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt; &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;$&lt;/td&gt; &lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;0.06&lt;/td&gt; &lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;&lt;/tbody&gt;&lt;/table&gt;</us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock>
    <us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic
      contextRef="cref_1083338889"
      decimals="0"
      id="ixv-4137"
      unitRef="uref_1046053354">2385647</us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic>
    <us-gaap:NetIncomeLossAvailableToCommonStockholdersDiluted
      contextRef="cref_1083338889"
      decimals="0"
      id="ixv-4138"
      unitRef="uref_1046053354">2385647</us-gaap:NetIncomeLossAvailableToCommonStockholdersDiluted>
    <us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic
      contextRef="cref_1326103014"
      decimals="0"
      id="ixv-4139"
      unitRef="uref_1046053354">785726</us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic>
    <us-gaap:NetIncomeLossAvailableToCommonStockholdersDiluted
      contextRef="cref_1326103014"
      decimals="0"
      id="ixv-4140"
      unitRef="uref_1046053354">785726</us-gaap:NetIncomeLossAvailableToCommonStockholdersDiluted>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="cref_1083338889"
      decimals="0"
      id="ixv-4141"
      unitRef="uref_1880167681">41900000</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="cref_1083338889"
      decimals="0"
      id="ixv-4142"
      unitRef="uref_1880167681">41900000</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="cref_1326103014"
      decimals="0"
      id="ixv-4143"
      unitRef="uref_1880167681">13800000</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="cref_1326103014"
      decimals="0"
      id="ixv-4144"
      unitRef="uref_1880167681">13800000</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:EarningsPerShareBasic
      contextRef="cref_1083338889"
      decimals="2"
      id="ixv-4145"
      unitRef="uref_123589252">0.06</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareBasic
      contextRef="cref_1083338889"
      decimals="2"
      id="ixv-4146"
      unitRef="uref_123589252">0.06</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareDiluted
      contextRef="cref_1326103014"
      decimals="2"
      id="ixv-4147"
      unitRef="uref_123589252">0.06</us-gaap:EarningsPerShareDiluted>
    <us-gaap:EarningsPerShareDiluted
      contextRef="cref_1326103014"
      decimals="2"
      id="ixv-4148"
      unitRef="uref_123589252">0.06</us-gaap:EarningsPerShareDiluted>
    <us-gaap:IncomeTaxPolicyTextBlock contextRef="cref_598338636" id="ixv-2151">&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;span style="font-weight: bold;"&gt;&lt;i&gt;Income Taxes&lt;/i&gt;&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 29.15pt; text-indent: 17.45pt"&gt;&#160;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;The Company accounts for income taxes under FASB ASC Topic&#160;740, &#x201c;Income Taxes,&#x201d; (&#x201c;ASC Topic 740&#x201d;) which requires an asset and liability approach to financial accounting and reporting for income taxes. Deferred income tax assets and liabilities are computed for differences between the financial statement and tax bases of assets and liabilities that will result in future taxable or deductible amounts, based on enacted tax laws and rates applicable to the periods in which the differences are expected to affect taxable income. Valuation allowances are established, when necessary, to reduce deferred tax assets to the amount expected to be realized.&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 29.15pt; text-indent: 17.45pt"&gt;&#160;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt; ASC Topic&#160;740 prescribes a recognition threshold and a measurement attribute for the financial statement recognition and measurement of tax positions taken or expected to be taken in a tax return. For those benefits to be recognized, a tax position must be more likely than not to be sustained upon examination by taxing authorities. The Company&#x2019;s management determined that the Cayman Islands is the Company&#x2019;s major tax jurisdiction. The Company recognizes accrued interest and penalties related to unrecognized tax benefits as income tax expense. As of March 31, 2026 and December 31, 2025, there were &lt;span style="-sec-ix-hidden:fc_495639681"&gt;no&lt;/span&gt; unrecognized tax benefits and &lt;span style="-sec-ix-hidden:fc_680601104"&gt;no&lt;/span&gt; amounts accrued for interest and penalties. The Company is currently not aware of any issues under review that could result in significant payments, accruals or material deviation from its position. &lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 29.15pt"&gt;&#160;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;The Company is considered to be an exempted Cayman Islands company with no connection to any other taxable jurisdiction and is presently not subject to income taxes or income tax filing requirements in the Cayman Islands or the United&#160;States. As such, the Company&#x2019;s tax provision was zero for the period presented.&lt;/p&gt;</us-gaap:IncomeTaxPolicyTextBlock>
    <us-gaap:SharesSubjectToMandatoryRedemptionChangesInRedemptionValuePolicyTextBlock contextRef="cref_598338636" id="ixv-2164">&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;span style="font-weight: bold;"&gt;&lt;i&gt;Class A Ordinary Shares Subject to Possible Redemption&lt;/i&gt;&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 29.15pt; text-indent: 17.45pt"&gt;&#160;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt; The Public Shares contain a redemption feature which allows for the redemption of such Public Shares in connection with the Company&#x2019;s liquidation, if there is a shareholder vote (A) to modify the substance or timing of the Company&#x2019;s obligation to allow redemption in connection with a Business Combination or to redeem 100% of the Public Shares if the Company does not complete an initial Business Combination within the completion window or (B) with respect to any other material provisions relating to shareholders&#x2019; rights or pre-initial Business Combination activity, or if there is a shareholder vote or tender offer in connection with the Company&#x2019;s initial Business Combination. In accordance with ASC 480-10-S99, the Company classifies Public Shares subject to redemption outside of permanent equity as the redemption provisions are not solely within the control of the Company. The Company recognizes changes in redemption value immediately as they occur and will adjust the carrying value of redeemable shares to equal the redemption value at the end of each reporting period. Immediately upon the closing of the Initial Public Offering, the Company recognized the accretion from initial book value to redemption value. The change in the carrying value of redeemable shares will result in charges against additional paid-in capital (to the extent available) and accumulated deficit. Accordingly, as of March 31, 2026 and December 31, 2025, Class A Ordinary Shares subject to possible redemption are presented at redemption value as temporary equity, outside of the shareholders&#x2019; deficit section of the Company&#x2019;s condensed balance sheets. As of March 31, 2026 and December 31, 2025, the Class A Ordinary Shares subject to possible redemption reflected in the condensed balance sheets are reconciled in the following table: &lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 39.25pt; text-indent: 17.8pt"&gt;&#160;&lt;/p&gt;&lt;table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif"&gt; &lt;tbody&gt;&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;&lt;td style="width: 88%; text-align: left"&gt;Gross proceeds&lt;/td&gt; &lt;td style="width: 1%"&gt;&#160;&lt;/td&gt; &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt; &lt;td style="width: 9%; text-align: right"&gt;414,000,000&lt;/td&gt; &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;&lt;tr style="vertical-align: bottom; background-color: White"&gt;&lt;td&gt;Less:&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt; &lt;td style="text-align: right"&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;&lt;td style="text-align: left"&gt;Proceeds allocated to Public Warrants&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt; &lt;td style="text-align: right"&gt;(2,028,600&lt;/td&gt; &lt;td style="text-align: left"&gt;)&lt;/td&gt; &lt;/tr&gt;&lt;tr style="vertical-align: bottom; background-color: White"&gt;&lt;td style="text-align: left"&gt;Public Shares issuance costs&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt; &lt;td style="text-align: right"&gt;(19,514,643&lt;/td&gt; &lt;td style="text-align: left"&gt;)&lt;/td&gt; &lt;/tr&gt;&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;&lt;td&gt;Plus:&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt; &lt;td style="text-align: right"&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;&lt;tr style="vertical-align: bottom; background-color: White"&gt;&lt;td style="padding-bottom: 1.5pt"&gt;Accretion of carrying value to redemption value&lt;/td&gt; &lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt; &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt; &lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;21,543,243&lt;/td&gt; &lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;&lt;td style="text-align: left"&gt;Class A Ordinary Shares subject to possible redemption, December 31, 2025&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt; &lt;td style="text-align: right"&gt;414,000,000&lt;/td&gt; &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;&lt;tr style="vertical-align: bottom; background-color: White"&gt;&lt;td&gt;Plus:&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt; &lt;td style="text-align: right"&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;&lt;td style="padding-bottom: 1.5pt"&gt;Accretion of carrying value to redemption value&lt;/td&gt; &lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt; &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt; &lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;3,094,829&lt;/td&gt; &lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;&lt;tr style="vertical-align: bottom; background-color: White"&gt;&lt;td style="text-align: left; padding-bottom: 2.5pt"&gt;Class A Ordinary Shares subject to possible redemption, March 31, 2026&lt;/td&gt; &lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt; &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;$&lt;/td&gt; &lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;417,094,829&lt;/td&gt; &lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;&lt;/tbody&gt;&lt;/table&gt;</us-gaap:SharesSubjectToMandatoryRedemptionChangesInRedemptionValuePolicyTextBlock>
    <ccxi:PercentageObligationToRedeemPublicSharesIfEntityDoesNotCompleteBusinessCombination
      contextRef="cref_598338636"
      decimals="2"
      id="ixv-4149"
      unitRef="uref_2103209578">1</ccxi:PercentageObligationToRedeemPublicSharesIfEntityDoesNotCompleteBusinessCombination>
    <us-gaap:TemporaryEquityTableTextBlock contextRef="cref_598338636" id="ixv-4150">As of March 31, 2026 and December 31, 2025, the Class A Ordinary Shares subject to possible redemption reflected in the condensed balance sheets are reconciled in the following table:&lt;table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif"&gt; &lt;tbody&gt;&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;&lt;td style="width: 88%; text-align: left"&gt;Gross proceeds&lt;/td&gt; &lt;td style="width: 1%"&gt;&#160;&lt;/td&gt; &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt; &lt;td style="width: 9%; text-align: right"&gt;414,000,000&lt;/td&gt; &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;&lt;tr style="vertical-align: bottom; background-color: White"&gt;&lt;td&gt;Less:&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt; &lt;td style="text-align: right"&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;&lt;td style="text-align: left"&gt;Proceeds allocated to Public Warrants&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt; &lt;td style="text-align: right"&gt;(2,028,600&lt;/td&gt; &lt;td style="text-align: left"&gt;)&lt;/td&gt; &lt;/tr&gt;&lt;tr style="vertical-align: bottom; background-color: White"&gt;&lt;td style="text-align: left"&gt;Public Shares issuance costs&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt; &lt;td style="text-align: right"&gt;(19,514,643&lt;/td&gt; &lt;td style="text-align: left"&gt;)&lt;/td&gt; &lt;/tr&gt;&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;&lt;td&gt;Plus:&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt; &lt;td style="text-align: right"&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;&lt;tr style="vertical-align: bottom; background-color: White"&gt;&lt;td style="padding-bottom: 1.5pt"&gt;Accretion of carrying value to redemption value&lt;/td&gt; &lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt; &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt; &lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;21,543,243&lt;/td&gt; &lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;&lt;td style="text-align: left"&gt;Class A Ordinary Shares subject to possible redemption, December 31, 2025&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt; &lt;td style="text-align: right"&gt;414,000,000&lt;/td&gt; &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;&lt;tr style="vertical-align: bottom; background-color: White"&gt;&lt;td&gt;Plus:&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt; &lt;td style="text-align: right"&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;&lt;td style="padding-bottom: 1.5pt"&gt;Accretion of carrying value to redemption value&lt;/td&gt; &lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt; &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt; &lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;3,094,829&lt;/td&gt; &lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;&lt;tr style="vertical-align: bottom; background-color: White"&gt;&lt;td style="text-align: left; padding-bottom: 2.5pt"&gt;Class A Ordinary Shares subject to possible redemption, March 31, 2026&lt;/td&gt; &lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt; &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;$&lt;/td&gt; &lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;417,094,829&lt;/td&gt; &lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;&lt;/tbody&gt;&lt;/table&gt;</us-gaap:TemporaryEquityTableTextBlock>
    <us-gaap:ProceedsFromIssuanceInitialPublicOffering
      contextRef="cref_1351018194"
      decimals="0"
      id="ixv-4151"
      unitRef="uref_1046053354">414000000</us-gaap:ProceedsFromIssuanceInitialPublicOffering>
    <us-gaap:ProceedsFromIssuanceOfWarrants
      contextRef="cref_1351018194"
      decimals="0"
      id="ixv-4152"
      unitRef="uref_1046053354">2028600</us-gaap:ProceedsFromIssuanceOfWarrants>
    <ccxi:PublicSharesIssuanceCost
      contextRef="cref_1351018194"
      decimals="0"
      id="ixv-4153"
      unitRef="uref_1046053354">-19514643</ccxi:PublicSharesIssuanceCost>
    <us-gaap:TemporaryEquityAccretionToRedemptionValueAdjustment
      contextRef="cref_1351018194"
      decimals="0"
      id="ixv-4154"
      unitRef="uref_1046053354">21543243</us-gaap:TemporaryEquityAccretionToRedemptionValueAdjustment>
    <us-gaap:TemporaryEquityCarryingAmountAttributableToParent
      contextRef="cref_1457352392"
      decimals="0"
      id="ixv-4155"
      unitRef="uref_1046053354">414000000</us-gaap:TemporaryEquityCarryingAmountAttributableToParent>
    <us-gaap:TemporaryEquityAccretionToRedemptionValueAdjustment
      contextRef="cref_2147129175"
      decimals="0"
      id="ixv-4156"
      unitRef="uref_1046053354">3094829</us-gaap:TemporaryEquityAccretionToRedemptionValueAdjustment>
    <us-gaap:TemporaryEquityCarryingAmountAttributableToParent
      contextRef="cref_1211178341"
      decimals="0"
      id="ixv-4157"
      unitRef="uref_1046053354">417094829</us-gaap:TemporaryEquityCarryingAmountAttributableToParent>
    <ccxi:WarrantInstrumentsPolicyTextBlock contextRef="cref_598338636" id="fc_229386638">&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;span style="font-weight: bold;"&gt;&lt;i&gt;Warrant Instruments&lt;/i&gt;&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 29.15pt; text-indent: 17.45pt"&gt;&#160;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt; The Company accounts for the Public and Private Warrants to be issued in connection with the Initial Public Offering and the private placement in accordance with the guidance contained in FASB ASC Topic&#160;815, &#x201c;Derivatives and Hedging.&#x201d; Accordingly, the Company evaluated and classified the warrant instruments under equity treatment at their assigned value. There are 4,140,000 Public Warrants (as defined in Note 1) and 50,000 Private Warrants (as defined in Note 4) currently outstanding as of March 31, 2026 and December 31, 2025. &lt;/p&gt;</ccxi:WarrantInstrumentsPolicyTextBlock>
    <us-gaap:ClassOfWarrantOrRightOutstanding
      contextRef="cref_344168120"
      decimals="0"
      id="ixv-4158"
      unitRef="uref_1880167681">4140000</us-gaap:ClassOfWarrantOrRightOutstanding>
    <us-gaap:ClassOfWarrantOrRightOutstanding
      contextRef="cref_92946457"
      decimals="0"
      id="ixv-4159"
      unitRef="uref_1880167681">50000</us-gaap:ClassOfWarrantOrRightOutstanding>
    <us-gaap:NewAccountingPronouncementsPolicyPolicyTextBlock contextRef="cref_598338636" id="ixv-2250">&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;span style="font-weight: bold;"&gt;&lt;i&gt;Recent Accounting Pronouncements&lt;/i&gt;&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 29.15pt; text-indent: 17.45pt"&gt;&#160;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;Management does not believe that any recently issued, but not effective, accounting standards, if currently adopted, would have a material effect on the Company&#x2019;s unaudited condensed financial statements.&lt;/p&gt;</us-gaap:NewAccountingPronouncementsPolicyPolicyTextBlock>
    <ccxi:InitialPublicOfferingTextBlock contextRef="cref_598338636" id="ixv-2258">&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-weight: bold;"&gt;Note&#160;3 &#x2014;&#160;Initial Public Offering&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 29.15pt; text-indent: 17.45pt"&gt;&#160;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt; Pursuant to the Initial Public Offering, the Company sold 41,400,000&#160;Units&#160;at a price of $10.00 per Unit for a total of $414&#160;million, which includes the full exercise of the underwriter&#x2019;s Over-Allotment Option. Each Unit consists of one Public Share and one-tenth of one warrant. Each Public Warrant entitles the holder to purchase one Class A Ordinary Share at a price of $11.50 per share, subject to adjustments (see Note&#160;7). &lt;/p&gt;</ccxi:InitialPublicOfferingTextBlock>
    <ccxi:UnitsIssuedDuringPeriodSharesNewIssues
      contextRef="cref_734378815"
      decimals="0"
      id="ixv-4160"
      unitRef="uref_1880167681">41400000</ccxi:UnitsIssuedDuringPeriodSharesNewIssues>
    <us-gaap:SharesIssuedPricePerShare
      contextRef="cref_1648036551"
      decimals="2"
      id="ixv-4161"
      unitRef="uref_123589252">10</us-gaap:SharesIssuedPricePerShare>
    <us-gaap:ProceedsFromIssuanceInitialPublicOffering
      contextRef="cref_734378815"
      decimals="-6"
      id="ixv-4162"
      unitRef="uref_1046053354">414000000</us-gaap:ProceedsFromIssuanceInitialPublicOffering>
    <us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
      contextRef="cref_769804437"
      decimals="2"
      id="fc_769804437"
      unitRef="uref_123589252">11.5</us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1>
    <ccxi:PrivatePlacementTextBlock contextRef="cref_598338636" id="ixv-2264">&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;span style="font-weight: bold;"&gt;Note&#160;4 &#x2014;&#160;Private Placement&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 29.15pt; text-indent: 17.45pt"&gt;&#160;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt; Simultaneously with the closing of the Initial Public Offering, the Sponsor purchased an aggregate of 500,000 Private Placement Units&#160;for an aggregate purchase price of $5,000,000. Each Private Placement Unit consists of one Class A Ordinary Share and one-tenth of one warrant (each, a &#x201c;Private Warrant,&#x201d; together with the Public Warrants, the &#x201c;Warrants&#x201d;). Each whole Private Warrant entitles the holder to purchase one Class A Ordinary Share at a price of $11.50 per share, subject to adjustments. Each warrant will become exercisable 30&#160;days after the completion of the initial Business Combination and will not expire except upon liquidation. If the initial Business Combination is not completed within the Combination Period, the proceeds from the sale of the Private Placement Warrants held in the Trust Account will be used to fund the redemption of the Public Shares (subject to the requirements of applicable law). &lt;/p&gt;</ccxi:PrivatePlacementTextBlock>
    <ccxi:UnitsIssuedDuringPeriodSharesNewIssues
      contextRef="cref_2094027022"
      decimals="0"
      id="ixv-4164"
      unitRef="uref_1880167681">500000</ccxi:UnitsIssuedDuringPeriodSharesNewIssues>
    <us-gaap:ProceedsFromIssuanceOfPrivatePlacement
      contextRef="cref_1055378908"
      decimals="0"
      id="ixv-4165"
      unitRef="uref_1046053354">5000000</us-gaap:ProceedsFromIssuanceOfPrivatePlacement>
    <us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight
      contextRef="cref_1928010055"
      decimals="0"
      id="ixv-4166"
      unitRef="uref_1880167681">1</us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight>
    <us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
      contextRef="cref_1928010055"
      decimals="2"
      id="ixv-4167"
      unitRef="uref_123589252">11.5</us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1>
    <ccxi:WarrantExercisableTerm contextRef="cref_1055378908" id="ixv-4168">P30D</ccxi:WarrantExercisableTerm>
    <us-gaap:RelatedPartyTransactionsDisclosureTextBlock contextRef="cref_598338636" id="ixv-2271">&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-weight: bold;"&gt;Note&#160;5 &#x2014;&#160;Related Party Transactions&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-weight: bold;"&gt;&lt;i&gt;&#160;&lt;/i&gt;&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;span style="font-weight: bold;"&gt;&lt;i&gt;Founder Shares&lt;/i&gt;&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 29.15pt; text-indent: 17.45pt"&gt;&#160;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt; On June&#160;4, 2025, the Company issued an aggregate of 8,625,000 Class&#160;B ordinary shares, $0.0001 par value (the &#x201c;Class B Ordinary Shares&#x201d;), in exchange for a $25,000 payment (approximately $0.003 per share) from the Sponsor to cover certain expenses on behalf of the Company (the &#x201c;Founder Shares,&#x201d; including the Public Shares issuable upon conversion thereof). In November 2025, the Company issued 2,875,000 Class B Ordinary Shares to the Sponsor by way of a share capitalization, resulting in the total number of issued and outstanding Class B Ordinary Shares increasing to 11,500,000. In December 2025, the Company, through a share capitalization, issued the Sponsor an additional 2,300,000 Founder Shares, for which the Sponsor now holds 13,800,000 Founder Shares in the aggregate. All share and per share data has been retrospectively presented. As used herein, unless the context otherwise requires, &#x201c;Founder Shares&#x201d; shall be deemed to include the Public Shares issuable upon conversion thereof. The Founder Shares are identical to the Public Shares included in the Units&#160;being sold in the Initial Public Offering except that the Founder Shares automatically convert into Public Shares at the time of the initial Business Combination (with such conversion taking place immediately prior to, simultaneously with, or immediately following the time of the initial Business Combination , as may be determined by the directors of the Company) or earlier at the option of the holder and are subject to certain transfer restrictions, as described in more detail below. The Sponsor will not be entitled to redemption rights with respect to any Founder Shares and any Public Shares held by the Sponsor in connection with the completion of the Initial Business Combination. If the initial Business Combination is not completed within the Combination Period, the Sponsor will not be entitled to rights to liquidating distributions from the Trust Account with respect to any Founder Shares held by it. &lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;The Sponsor has agreed not to transfer, assign or sell any of its Founder Shares until the earlier to occur of (A)&#160;six&#160;months after the completion of the initial Business Combination or (B)&#160;subsequent to the initial Business Combination (the date on which the Company consummates a transaction which results in the shareholders having the right to exchange their shares for cash, securities, or other property subject to certain limited exceptions).&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;span style="font-weight: bold;"&gt;&lt;i&gt;Promissory Note&#160;&#x2014;&#160;Related Party&lt;/i&gt;&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 29.15pt"&gt;&#160;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt; On June&#160;4, 2025, the Company and the Sponsor entered into a loan agreement, whereby the Sponsor agreed to loan the Company an aggregate of up to $600,000 to cover expenses related to the Initial Public Offering pursuant to a promissory note. This loan is non-interest bearing and payable on the earlier of December&#160;31, 2025, or the date on which the Company consummates the Initial Public Offering. The Company repaid the entire outstanding balance of $356,062 at the closing of the Initial Public Offering. Borrowings under the note are no longer available. &lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-weight: bold;"&gt;&lt;i&gt;&#160;&lt;/i&gt;&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;span style="font-weight: bold;"&gt;&lt;i&gt;Administrative Support Agreement&lt;/i&gt;&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 29.15pt; text-indent: 17.45pt"&gt;&#160;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"&gt; Commencing on the date of the securities of the Company are first listed, December 17, 2025, the Company agreed to reimburse the managing member of the Sponsor in an amount equal to $30,000 per month for office space, utilities and secretarial and administrative support. Upon completion of the Initial Business Combination or the Company&#x2019;s liquidation, the Company will cease paying these monthly fees. For the three months ended March 31, 2026, we incurred and paid $90,000 in fees for these services. &lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-weight: bold;"&gt;&lt;i&gt;&#160;&lt;/i&gt;&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;span style="font-weight: bold;"&gt;&lt;i&gt;Director Agreement&lt;/i&gt;&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-weight: bold;"&gt;&lt;i&gt;&#160;&lt;/i&gt;&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"&gt; On March 17, 2026, the Company entered into a director agreement with each of its independent directors, pursuant to which, in connection with each director&#x2019;s continuing service as a director of the Company, the Company agreed to pay each director cash compensation of $75,000 per annum, beginning on April 1, 2026. For the three months ended March 31, 2026, &lt;span style="-sec-ix-hidden:fc_2027863549"&gt;no&lt;/span&gt; fees were incurred for these services. &lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;span style="font-weight: bold;"&gt;&lt;i&gt;Working Capital Loans&lt;/i&gt;&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 29.15pt; text-indent: 17.45pt"&gt;&#160;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt; In addition, in order to finance transaction costs in connection with its initial Business Combination, the Sponsor or an affiliate of the Sponsor, or the Company&#x2019;s officers and directors may, but are not obligated to, loan the Company funds as may be required (&#x201c;Working Capital Loans&#x201d;). If the Company completes its initial Business Combination, the Company would repay the Working Capital Loans. In the event that the initial Business Combination does not close, the Company may use a portion of proceeds held outside the Trust Account to repay the Working Capital Loans but no proceeds held in the Trust Account would be used to repay the Working Capital Loans. If the Sponsor makes any Working Capital Loans, up to $1,500,000 of such loans may be convertible into units of the post Business Combination entity at a price of $10.00 per unit at the option of the lender. The units and their underlying securities would be identical to the Private Placement Units (and underlying securities). As of March 31, 2026 and December 31, 2025, the Company had &lt;span style="-sec-ix-hidden:fc_1234813798"&gt;&lt;span style="-sec-ix-hidden:fc_708786138"&gt;no&lt;/span&gt;&lt;/span&gt; borrowings under the Working Capital Loans. &lt;/p&gt;</us-gaap:RelatedPartyTransactionsDisclosureTextBlock>
    <us-gaap:StockIssuedDuringPeriodSharesNewIssues
      contextRef="cref_1716086651"
      decimals="0"
      id="ixv-4169"
      unitRef="uref_1880167681">8625000</us-gaap:StockIssuedDuringPeriodSharesNewIssues>
    <us-gaap:CommonStockParOrStatedValuePerShare
      contextRef="cref_2056961191"
      decimals="4"
      id="ixv-4170"
      unitRef="uref_123589252">0.0001</us-gaap:CommonStockParOrStatedValuePerShare>
    <us-gaap:StockIssuedDuringPeriodValueNewIssues
      contextRef="cref_1716086651"
      decimals="0"
      id="ixv-4171"
      unitRef="uref_1046053354">25000</us-gaap:StockIssuedDuringPeriodValueNewIssues>
    <us-gaap:SharePrice
      contextRef="cref_2127870742"
      decimals="3"
      id="ixv-4172"
      unitRef="uref_123589252">0.003</us-gaap:SharePrice>
    <us-gaap:StockIssuedDuringPeriodSharesOther
      contextRef="cref_1102980629"
      decimals="0"
      id="fc_1102980629"
      unitRef="uref_1880167681">2875000</us-gaap:StockIssuedDuringPeriodSharesOther>
    <us-gaap:CommonStockSharesIssued
      contextRef="cref_1721169663"
      decimals="0"
      id="ixv-4174"
      unitRef="uref_1880167681">11500000</us-gaap:CommonStockSharesIssued>
    <us-gaap:CommonStockSharesOutstanding
      contextRef="cref_1721169663"
      decimals="0"
      id="ixv-4175"
      unitRef="uref_1880167681">11500000</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:StockIssuedDuringPeriodSharesOther
      contextRef="cref_415477080"
      decimals="0"
      id="ixv-4176"
      unitRef="uref_1880167681">2300000</us-gaap:StockIssuedDuringPeriodSharesOther>
    <us-gaap:StockIssuedDuringPeriodSharesOther
      contextRef="cref_1429513406"
      decimals="0"
      id="ixv-4177"
      unitRef="uref_1880167681">13800000</us-gaap:StockIssuedDuringPeriodSharesOther>
    <us-gaap:OtherExpenses
      contextRef="cref_1043500938"
      decimals="0"
      id="ixv-4178"
      unitRef="uref_1046053354">600000</us-gaap:OtherExpenses>
    <us-gaap:RepaymentsOfRelatedPartyDebt
      contextRef="cref_1044380028"
      decimals="0"
      id="ixv-4179"
      unitRef="uref_1046053354">356062</us-gaap:RepaymentsOfRelatedPartyDebt>
    <us-gaap:AdministrativeFeesExpense
      contextRef="cref_1030443559"
      decimals="0"
      id="ixv-4180"
      unitRef="uref_1046053354">30000</us-gaap:AdministrativeFeesExpense>
    <us-gaap:PaymentsForFees
      contextRef="cref_598338636"
      decimals="0"
      id="ixv-4181"
      unitRef="uref_1046053354">90000</us-gaap:PaymentsForFees>
    <us-gaap:PaymentsForFees
      contextRef="cref_811510108"
      decimals="0"
      id="ixv-4182"
      unitRef="uref_1046053354">75000</us-gaap:PaymentsForFees>
    <ccxi:WorkingCapitalLoan
      contextRef="cref_176815138"
      decimals="0"
      id="ixv-4183"
      unitRef="uref_1046053354">1500000</ccxi:WorkingCapitalLoan>
    <us-gaap:SharePrice
      contextRef="cref_176815138"
      decimals="2"
      id="ixv-4184"
      unitRef="uref_123589252">10</us-gaap:SharePrice>
    <us-gaap:CommitmentsAndContingenciesDisclosureTextBlock contextRef="cref_598338636" id="ixv-2325">&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;span style="font-weight: bold;"&gt;Note&#160;6 &#x2014;&#160;Commitments and Contingencies&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 29.15pt"&gt;&lt;span style="font-weight: bold;"&gt;&lt;i&gt;&#160;&lt;/i&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"&gt;&lt;span style="font-weight: bold;"&gt;&lt;i&gt;Risks and Uncertainties&lt;/i&gt;&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"&gt;&#160;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"&gt;The Company&#x2019;s ability to complete an initial Business Combination may be adversely affected by various factors, many of which are beyond the Company&#x2019;s control. The Company&#x2019;s ability to consummate an initial Business Combination could be impacted by, among other things, changes in laws or regulations, downturns in the financial markets or in economic conditions, inflation, fluctuations in interest rates, increases in tariffs, supply chain disruptions, declines in consumer confidence and spending, public health considerations, and geopolitical instability, such as the military conflicts in Ukraine, between the United States, Israel and Iran and others in the Middle East, and Southwest Asia or other armed hostilities. The Company cannot at this time predict the likelihood of one or more of the above events, their duration or magnitude or the extent to which they may negatively impact the Company&#x2019;s ability to complete an initial Business Combination.&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;span style="font-weight: bold;"&gt;&lt;i&gt;Registration Rights&lt;/i&gt;&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 29.15pt; text-indent: 17.45pt"&gt;&#160;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;The holders of Founder Shares, Private Placement Units&#160;(and their underlying securities) and Units&#160;that may be issued upon conversion of working capital loans (and their underlying securities), if any, and any Class A Ordinary Shares issuable upon conversion of the Founder Shares and any Class A Ordinary Shares held by the initial shareholders at the completion of the Initial Public Offering or acquired prior to or in connection with the initial Business Combination, will be entitled to registration rights pursuant to a registration rights agreement to be signed prior to or on the effective date of the registration statement for the Initial Public Offering. These holders will be entitled to make up to three demands and have &#x201c;piggyback&#x201d; registration rights. The Company will bear the expenses incurred in connection with the filing of any such registration statements.&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 11.25pt; text-align: justify"&gt;&lt;span style="font-weight: bold;"&gt;&lt;i&gt;&#160;&lt;/i&gt;&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;span style="font-weight: bold;"&gt;&lt;i&gt;Underwriter&#x2019;s Agreement&lt;/i&gt;&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 29.15pt; text-indent: 17.45pt"&gt;&#160;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt; The Company granted the underwriter 45-day option from the date of the Initial Public Offering to purchase up to an additional 5,400,000&#160;units to cover over-allotments, if any (the &#x201c;Over-Allotment Option&#x201d;). On December 18, 2025, the underwriter elected to fully exercise their Over-Allotment Option to purchase an additional 5,400,000 Units at a price of $10.00 per Unit. &lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 29.15pt; text-indent: 17.45pt"&gt;&#160;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt; The underwriter was entitled to a cash underwriting discount of $0.15 per Unit, $6,210,000 which was paid to the underwriter upon the closing of the Initial Public Offering. The underwriter paid the Company an aggregate amount of $3,210,000 at the closing of the Initial Public Offering as reimbursement to the Company for certain of its expenses and fees incurred in connection with the Initial Public Offering. &lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 29.15pt"&gt;&#160;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt; Additionally, the underwriter is entitled to a Deferred Fee of $15,990,000, of which (x) $14,490,000 was placed in the Trust Account located in the United States and released to the underwriter only upon the completion of an initial Business Combination and (y) $1,500,000 which will be payable to the underwriter from funds available outside the Trust Account upon the announcement that the Company has entered into a definitive Business Combination agreement. &lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;span style="font-weight: bold;"&gt;&lt;i&gt;Legal Fees&lt;/i&gt;&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;span style="font-weight: bold;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt; On March 25, 2026, the Company entered into an agreement for legal services. All fees related to the agreement are contingent upon the completion of a Business Combination. Upon the completion of the Business Combination, in addition to payment of incurred fees, the Company will pay a premium ranging from 50% to 100% of the fees incurred, with the percentage paid to be determined at the discretion of the Company. As of March 31, 2026, the Company has incurred $235,000 of fees in connection with the agreement. These fees are not reflected in the condensed consolidated financial statements and will be recorded when the Business Combination is considered probable. &lt;/p&gt;</us-gaap:CommitmentsAndContingenciesDisclosureTextBlock>
    <ccxi:UnderwritingOptionPeriod contextRef="cref_543469871" id="ixv-4185">P45D</ccxi:UnderwritingOptionPeriod>
    <ccxi:UnitsIssuedDuringPeriodSharesNewIssues
      contextRef="cref_154218680"
      decimals="0"
      id="ixv-4186"
      unitRef="uref_1880167681">5400000</ccxi:UnitsIssuedDuringPeriodSharesNewIssues>
    <ccxi:UnitsIssuedDuringPeriodSharesNewIssues
      contextRef="cref_1117640675"
      decimals="0"
      id="fc_1117640675"
      unitRef="uref_1880167681">5400000</ccxi:UnitsIssuedDuringPeriodSharesNewIssues>
    <us-gaap:SaleOfStockPricePerShare
      contextRef="cref_1206905538"
      decimals="2"
      id="fc_1206905538"
      unitRef="uref_123589252">10</us-gaap:SaleOfStockPricePerShare>
    <ccxi:UnderwritingDiscountAmountPerUnit
      contextRef="cref_440113746"
      decimals="2"
      id="ixv-4189"
      unitRef="uref_123589252">0.15</ccxi:UnderwritingDiscountAmountPerUnit>
    <us-gaap:PaymentsForUnderwritingExpense
      contextRef="cref_734378815"
      decimals="0"
      id="ixv-4190"
      unitRef="uref_1046053354">6210000</us-gaap:PaymentsForUnderwritingExpense>
    <us-gaap:ProceedsFromIssuanceInitialPublicOffering
      contextRef="cref_543469871"
      decimals="0"
      id="ixv-4191"
      unitRef="uref_1046053354">3210000</us-gaap:ProceedsFromIssuanceInitialPublicOffering>
    <ccxi:DeferredUnderwritingFeeNoncurrent
      contextRef="cref_1622821628"
      decimals="0"
      id="ixv-4192"
      unitRef="uref_1046053354">15990000</ccxi:DeferredUnderwritingFeeNoncurrent>
    <ccxi:DeferredFeePlacedInTrustAccount
      contextRef="cref_543469871"
      decimals="0"
      id="ixv-4193"
      unitRef="uref_1046053354">14490000</ccxi:DeferredFeePlacedInTrustAccount>
    <us-gaap:PaymentsForUnderwritingExpense
      contextRef="cref_440113746"
      decimals="0"
      id="ixv-4194"
      unitRef="uref_1046053354">1500000</us-gaap:PaymentsForUnderwritingExpense>
    <ccxi:PremiumRangingPercentage
      contextRef="cref_1061322807"
      decimals="2"
      id="ixv-4195"
      unitRef="uref_2103209578">0.50</ccxi:PremiumRangingPercentage>
    <ccxi:PremiumRangingPercentage
      contextRef="cref_2103209578"
      decimals="2"
      id="ixv-4196"
      unitRef="uref_2103209578">1</ccxi:PremiumRangingPercentage>
    <us-gaap:LegalFees
      contextRef="cref_598338636"
      decimals="0"
      id="fc_1833434094"
      unitRef="uref_1046053354">235000</us-gaap:LegalFees>
    <us-gaap:StockholdersEquityNoteDisclosureTextBlock contextRef="cref_598338636" id="ixv-2370">&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;span style="font-weight: bold;"&gt;Note&#160;7 &#x2014;&#160;Shareholders&#x2019; Deficit&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-weight: bold;"&gt;&lt;i&gt;&#160;&lt;/i&gt;&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-weight: bold;"&gt;&lt;i&gt;Preference Shares&lt;/i&gt;&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt; The Company is authorized to issue 5,000,000 preference shares with a par value of $0.0001 per share with such designations, voting and other rights and preferences as may be determined from time to time by the Company&#x2019;s board of directors. As of March 31, 2026 and December 31, 2025, there were &lt;span style="-sec-ix-hidden:fc_1147257839"&gt;&lt;span style="-sec-ix-hidden:fc_1656918921"&gt;&lt;span style="-sec-ix-hidden:fc_1920448683"&gt;&lt;span style="-sec-ix-hidden:fc_794424461"&gt;no&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt; preference shares issued or outstanding. &lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-weight: bold;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-weight: bold;"&gt;&lt;i&gt;Class&#160;A Ordinary Shares&lt;/i&gt;&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt; The Company is authorized to issue a total of 500,000,000 Class A Ordinary Shares at par value of $0.0001 per share. As of March 31, 2026 and December 31, 2025, there were 500,000 Class A Ordinary Shares issued and outstanding, excluding 41,400,000 shares subject to possible redemption. &lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-weight: bold;"&gt;&lt;i&gt;Class&#160;B Ordinary Shares&lt;/i&gt;&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt; The Company is authorized to issue a total of 50,000,000 Class&#160;B ordinary shares at par value of $0.0001 per share. As of March 31, 2026 and December 31, 2025, there were 13,800,000 Class B Ordinary Shares issued and outstanding, which included an aggregate of up to 1,800,000 shares subject to forfeiture if the Over-Allotment Option is not exercised by the underwriter in full. As a result of the full exercise of the Over-Allotment Option by the underwriter, the 1,800,000 Founder Shares are no longer subject to forfeiture. &lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-weight: bold;"&gt;&lt;i&gt;Warrants&lt;/i&gt;&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-weight: bold;"&gt;&lt;i&gt;&#160;&lt;/i&gt;&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt; As of March 31, 2026 and December 31, 2025, there were 4,140,000 Public Warrants and 50,000 Private Placement Warrants outstanding. Each whole warrant entitles the holder thereof to purchase one whole Class A Ordinary Share at a price of $11.50 per share, subject to adjustment as described herein, at any time commencing 30&#160;days after the completion of the initial Business Combination, provided that the Company has an effective registration statement under the Securities Act covering the Class A Ordinary Shares issuable upon exercise of the Warrants and a current prospectus relating to them is available (or the Company permits holders to exercise their Warrants on a &#x201c;cashless basis&#x201d; under the circumstances specified in the warrant agreement) and such shares are registered, qualified or exempt from registration under the securities, or blue sky, laws of the state of residence of the holder. Pursuant to the (i) Public Warrant Agreement, dated December 16, 2025, which the Company entered into with Continental Stock Transfer &amp;amp; Trust Company (&#x201c;Continental&#x201d;), as Public Warrant agent and (ii) Private Warrant Agreement, dated December 16, 2025, which the Company entered into with Continental, as Private Placement Warrant agent ((i) and (ii) together, the &#x201c;Warrant Agreements&#x201d;), a warrant holder may exercise its Warrants only for a whole number of Class A Ordinary Shares. This means that only a whole warrant may be exercised at any given time by a warrant holder. No fractional Warrants will be issued upon separation of the units and only whole Warrants will trade. The Public Warrants will expire five&#160;years after the completion of the initial Business Combination, at 5:00&#160;p.m., New&#160;York City time, or earlier upon redemption or liquidation. &lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 29.15pt; text-indent: 17.45pt"&gt;&#160;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt; Company has agreed that as soon as practicable, but in no event later than fifteen (15)&#160;business days after the closing of the initial Business Combination, the Company will use its commercially best efforts to file with the SEC a post-effective amendment to the registration statement or a new registration statement registering, under the Securities Act, the issuance of the Public Shares issuable upon exercise of the Warrants. The Company will use its best efforts to cause the same to become effective and to maintain the effectiveness of such registration statement, and a current prospectus relating thereto, until the expiration of the Warrants in accordance with the provisions of the applicable warrant agreement. Notwithstanding the above, if the Public Shares are at the time of any exercise of a warrant not listed on a national securities exchange such that it satisfies the definition of a &#x201c;covered security&#x201d; under Section&#160;18(b)(1)&#160;of the Securities Act, the Company may, at its option, require holders of Warrants who exercise their Warrants to do so on a &#x201c;cashless basis&#x201d; in accordance with Section&#160;3(a)(9)&#160;of the Securities Act and, in the event the Company so elects, it will not be required to file or maintain in effect a registration statement, but the Company will be required to use its best efforts to register or qualify the shares under applicable blue sky laws to the extent an exemption is not available. &lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 14.55pt"&gt;&#160;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt; &lt;i&gt;Redemption of Public Warrants for cash when the price per Class A Ordinary Shares equals or exceeds $18.00&lt;/i&gt;. Beginning 30&#160;days after completion of the initial Business Combination, the Company may redeem the outstanding Public Warrants for cash: &lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 64.15pt; text-indent: -17.55pt"&gt;&#160;&lt;/p&gt;&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"&gt; &lt;tbody&gt;&lt;tr style="vertical-align: top"&gt;&lt;td style="width: 0.5in; text-align: justify"&gt;&#160;&lt;/td&gt; &lt;td style="width: 0.25in"&gt;&lt;span style="font-size: 10pt"&gt;&#x25cf;&lt;/span&gt;&lt;/td&gt; &lt;td style="text-align: justify"&gt;&lt;span style="font-size: 10pt"&gt;In whole and not in part;&lt;/span&gt;&lt;/td&gt; &lt;/tr&gt;&lt;/tbody&gt;&lt;/table&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 64.15pt; text-indent: -17.55pt"&gt;&#160;&lt;/p&gt;&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"&gt; &lt;tbody&gt;&lt;tr style="vertical-align: top"&gt;&lt;td style="width: 0.5in; text-align: justify"&gt;&#160;&lt;/td&gt; &lt;td style="width: 0.25in"&gt;&lt;span style="font-size: 10pt"&gt;&#x25cf;&lt;/span&gt;&lt;/td&gt; &lt;td style="text-align: justify"&gt;&lt;span style="font-size: 10pt"&gt;At a price of $0.01 per Warrant;&lt;/span&gt;&lt;/td&gt; &lt;/tr&gt;&lt;/tbody&gt; &lt;/table&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 64.15pt; text-indent: -17.55pt"&gt;&#160;&lt;/p&gt;&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"&gt; &lt;tbody&gt;&lt;tr style="vertical-align: top"&gt;&lt;td style="width: 0.5in; text-align: justify"&gt;&#160;&lt;/td&gt; &lt;td style="width: 0.25in"&gt;&lt;span style="font-size: 10pt"&gt;&#x25cf;&lt;/span&gt;&lt;/td&gt; &lt;td style="text-align: justify"&gt;&lt;span style="font-size: 10pt"&gt;Upon not less than 30&#160;days&#x2019; prior written notice of redemption (the &#x201c;30-day redemption period&#x201d;); and&lt;/span&gt;&lt;/td&gt; &lt;/tr&gt;&lt;/tbody&gt; &lt;/table&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 64.15pt; text-indent: -17.55pt"&gt;&#160;&lt;/p&gt;&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"&gt; &lt;tbody&gt;&lt;tr style="vertical-align: top"&gt;&lt;td style="width: 0.5in; text-align: justify"&gt;&#160;&lt;/td&gt; &lt;td style="width: 0.25in"&gt;&lt;span style="font-size: 10pt"&gt;&#x25cf;&lt;/span&gt;&lt;/td&gt; &lt;td style="text-align: justify"&gt;&lt;span style="font-size: 10pt"&gt;if, and only if, the last sale price of the Class A Ordinary Shares equals or exceeds $18.00 per share (as adjusted for share subdivisions, share dividends, reorganizations, recapitalizations and the like) for any 20&#160;trading days within a 30&#160;trading day period ending on the third&#160;trading day prior to the date on which the Company sends the notice of redemption to the warrant holders. The Company will not redeem the Warrants as described above unless a registration statement under the Securities Act covering the Class A Ordinary Shares issuable upon exercise of the Warrants is effective and a current prospectus relating to those Class A Ordinary Shares is available throughout such 30&#160;trading day period and the 30-day redemption period.&lt;/span&gt;&lt;/td&gt; &lt;/tr&gt;&lt;/tbody&gt; &lt;/table&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 29.15pt; text-indent: 17.45pt"&gt;&#160;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;The Private Placement Warrants contained in the Private Placement Units&#160;are non-redeemable. The Private Placement Warrants may also be exercised for cash or on a &#x201c;cashless basis.&#x201d; The Private Warrants do not expire except upon liquidation.&lt;/p&gt;</us-gaap:StockholdersEquityNoteDisclosureTextBlock>
    <us-gaap:PreferredStockSharesAuthorized
      contextRef="cref_886637457"
      decimals="0"
      id="ixv-4198"
      unitRef="uref_1880167681">5000000</us-gaap:PreferredStockSharesAuthorized>
    <us-gaap:PreferredStockParOrStatedValuePerShare
      contextRef="cref_886637457"
      decimals="4"
      id="ixv-4199"
      unitRef="uref_123589252">0.0001</us-gaap:PreferredStockParOrStatedValuePerShare>
    <us-gaap:CommonStockSharesAuthorized
      contextRef="cref_438597182"
      decimals="0"
      id="ixv-4200"
      unitRef="uref_1880167681">500000000</us-gaap:CommonStockSharesAuthorized>
    <us-gaap:CommonStockParOrStatedValuePerShare
      contextRef="cref_438597182"
      decimals="4"
      id="ixv-4201"
      unitRef="uref_123589252">0.0001</us-gaap:CommonStockParOrStatedValuePerShare>
    <us-gaap:CommonStockSharesIssued
      contextRef="cref_438597182"
      decimals="0"
      id="ixv-4202"
      unitRef="uref_1880167681">500000</us-gaap:CommonStockSharesIssued>
    <us-gaap:CommonStockSharesOutstanding
      contextRef="cref_165471328"
      decimals="0"
      id="ixv-4203"
      unitRef="uref_1880167681">500000</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:CommonStockSharesIssued
      contextRef="cref_438597182"
      decimals="0"
      id="ixv-4204"
      unitRef="uref_1880167681">500000</us-gaap:CommonStockSharesIssued>
    <us-gaap:CommonStockSharesOutstanding
      contextRef="cref_165471328"
      decimals="0"
      id="ixv-4205"
      unitRef="uref_1880167681">500000</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:TemporaryEquitySharesIssued
      contextRef="cref_438597182"
      decimals="0"
      id="ixv-4206"
      unitRef="uref_1880167681">41400000</us-gaap:TemporaryEquitySharesIssued>
    <us-gaap:CommonStockSharesAuthorized
      contextRef="cref_51160283"
      decimals="0"
      id="ixv-4207"
      unitRef="uref_1880167681">50000000</us-gaap:CommonStockSharesAuthorized>
    <us-gaap:CommonStockParOrStatedValuePerShare
      contextRef="cref_51160283"
      decimals="4"
      id="ixv-4208"
      unitRef="uref_123589252">0.0001</us-gaap:CommonStockParOrStatedValuePerShare>
    <us-gaap:CommonStockSharesIssued
      contextRef="cref_51160283"
      decimals="0"
      id="ixv-4209"
      unitRef="uref_1880167681">13800000</us-gaap:CommonStockSharesIssued>
    <us-gaap:CommonStockSharesOutstanding
      contextRef="cref_107229769"
      decimals="0"
      id="ixv-4210"
      unitRef="uref_1880167681">13800000</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:CommonStockSharesIssued
      contextRef="cref_51160283"
      decimals="0"
      id="ixv-4211"
      unitRef="uref_1880167681">13800000</us-gaap:CommonStockSharesIssued>
    <us-gaap:CommonStockSharesOutstanding
      contextRef="cref_107229769"
      decimals="0"
      id="ixv-4212"
      unitRef="uref_1880167681">13800000</us-gaap:CommonStockSharesOutstanding>
    <ccxi:NumberOfSharesSubjectToForfeiture
      contextRef="cref_51160283"
      decimals="0"
      id="ixv-4213"
      unitRef="uref_1880167681">1800000</ccxi:NumberOfSharesSubjectToForfeiture>
    <ccxi:NumberOfShareSubjectNoLongerToForfeiture
      contextRef="cref_1880167681"
      decimals="0"
      id="ixv-4214"
      unitRef="uref_1880167681">1800000</ccxi:NumberOfShareSubjectNoLongerToForfeiture>
    <us-gaap:WarrantsAndRightsOutstanding
      contextRef="cref_344168120"
      decimals="0"
      id="ixv-4215"
      unitRef="uref_1046053354">4140000</us-gaap:WarrantsAndRightsOutstanding>
    <us-gaap:WarrantsAndRightsOutstanding
      contextRef="cref_1273373180"
      decimals="0"
      id="ixv-4216"
      unitRef="uref_1046053354">50000</us-gaap:WarrantsAndRightsOutstanding>
    <us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
      contextRef="cref_1685859283"
      decimals="2"
      id="ixv-4217"
      unitRef="uref_123589252">11.5</us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1>
    <ccxi:NumberOfBusinessCombination contextRef="cref_1083338889" id="ixv-4218">P30D</ccxi:NumberOfBusinessCombination>
    <ccxi:NumberOfBusinessCombination contextRef="cref_598338636" id="ixv-4219">P15D</ccxi:NumberOfBusinessCombination>
    <us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
      contextRef="cref_438597182"
      decimals="2"
      id="ixv-4220"
      unitRef="uref_123589252">18</us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1>
    <ccxi:NumberOfBusinessCombination contextRef="cref_1083338889" id="ixv-4221">P30D</ccxi:NumberOfBusinessCombination>
    <us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
      contextRef="cref_789349549"
      decimals="2"
      id="ixv-4222"
      unitRef="uref_123589252">0.01</us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1>
    <ccxi:PriorWrittenNoticeRedemptionPeriod contextRef="cref_402311162" id="ixv-4223">P30D</ccxi:PriorWrittenNoticeRedemptionPeriod>
    <us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
      contextRef="cref_123589252"
      decimals="2"
      id="ixv-4224"
      unitRef="uref_123589252">18</us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1>
    <ccxi:NumberOfTradingDays contextRef="cref_40809227" id="ixv-4225">P20D</ccxi:NumberOfTradingDays>
    <ccxi:NumberOfTradingDays contextRef="cref_1965182610" id="ixv-4226">P30D</ccxi:NumberOfTradingDays>
    <ccxi:NumberOfTradingDays contextRef="cref_598338636" id="ixv-4227">P30D</ccxi:NumberOfTradingDays>
    <ccxi:NumberOfTradingDays contextRef="cref_1083338889" id="ixv-4228">P30D</ccxi:NumberOfTradingDays>
    <us-gaap:SegmentReportingDisclosureTextBlock contextRef="cref_598338636" id="ixv-2458">&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-weight: bold;"&gt;Note 8 &#x2014; Segment Information &lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-weight: bold;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;FASB ASC Topic 280, &#x201c;Segment Reporting,&#x201d; establishes standards for companies to report in their financial statement information about operating segments, products, services, geographic areas, and major customers. Operating segments are defined as components of an enterprise for which separate financial information is available that is regularly evaluated by the Company&#x2019;s chief operating decision makers (&#x201c;CODMs&#x201d;), or group, in deciding how to allocate resources and assess performance.&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt; The Company&#x2019;s CODMs have been identified as the &lt;span style="-sec-ix-hidden:fc_1200964243"&gt;Chief Executive Officer&lt;/span&gt; and the &lt;span style="-sec-ix-hidden:fc_715216225"&gt;Chief Financial Officer&lt;/span&gt;, who review the operating results for the Company as a whole to make decisions about allocating resources and assessing financial performance. Accordingly, management has determined that the Company only has one operating segment. &lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;The CODMs assesses performance for the single segment and decides how to allocate resources based on net income or loss that also is reported on the unaudited condensed statement of operations as net income or loss. The measure of segment assets is reported on the condensed balance sheets as total assets.&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;When evaluating the Company&#x2019;s performance and making key decisions regarding resource allocation the CODMs reviews several key metrics, which include the following:&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"&gt; &lt;tbody&gt;&lt;tr style="vertical-align: bottom"&gt;&lt;td style="white-space: nowrap; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt; &lt;td style="white-space: nowrap; padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt; &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; white-space: nowrap; font-weight: bold; text-align: center"&gt;March 31,&lt;br/&gt; 2026&lt;/td&gt; &lt;td style="white-space: nowrap; padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt; &lt;td style="white-space: nowrap; padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt; &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; white-space: nowrap; font-weight: bold; text-align: center"&gt;December 31,&lt;br/&gt; 2025&lt;/td&gt; &lt;td style="white-space: nowrap; padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;&lt;td style="width: 76%; text-indent: -6.5pt; padding-left: 6.5pt"&gt;Cash&lt;/td&gt; &lt;td style="width: 1%"&gt;&#160;&lt;/td&gt; &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt; &lt;td style="width: 9%; text-align: right"&gt;410,097&lt;/td&gt; &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt; &lt;td style="width: 1%"&gt;&#160;&lt;/td&gt; &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt; &lt;td style="width: 9%; text-align: right"&gt;736,204&lt;/td&gt; &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;&lt;tr style="vertical-align: bottom; background-color: White"&gt;&lt;td style="text-align: left; text-indent: -6.5pt; padding-left: 6.5pt"&gt;Marketable securities and cash held in Trust Account&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left"&gt;$&lt;/td&gt; &lt;td style="text-align: right"&gt;418,094,829&lt;/td&gt; &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left"&gt;$&lt;/td&gt; &lt;td style="text-align: right"&gt;414,549,783&lt;/td&gt; &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;&lt;/tbody&gt;&lt;/table&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 14.55pt"&gt;&#160;&lt;/p&gt;&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"&gt; &lt;tbody&gt;&lt;tr style="vertical-align: bottom"&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt; &lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt; &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;For the&lt;br/&gt; Three&lt;br/&gt;  Months&lt;br/&gt;  Ended&lt;br/&gt; March 31,&lt;br/&gt; 2026&lt;/td&gt; &lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;&lt;td style="width: 88%; text-align: left"&gt;General and administrative costs&lt;/td&gt; &lt;td style="width: 1%"&gt;&#160;&lt;/td&gt; &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt; &lt;td style="width: 9%; text-align: right"&gt;373,673&lt;/td&gt; &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;&lt;tr style="vertical-align: bottom; background-color: White"&gt;&lt;td style="text-align: left"&gt;Interest earned on marketable securities and cash held in Trust Account&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left"&gt;$&lt;/td&gt; &lt;td style="text-align: right"&gt;3,545,046&lt;/td&gt; &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;&lt;/tbody&gt;&lt;/table&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;The CODMs review interest earned on marketable securities and cash held in Trust Account to measure and monitor shareholder value and determine the most effective strategy of investment with the Trust Account funds while maintaining compliance with the Trust Agreement.&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;General and administrative costs are reviewed and monitored by the CODMs to manage and forecast cash to ensure enough capital is available to complete a Business Combination or similar transaction within the Business Combination period. The CODMs also review general and administrative costs to manage, maintain and enforce all contractual agreements to ensure costs are aligned with all agreements and budget. General and administrative costs, as reported on the accompanying unaudited condensed statement of operations, are the significant segment expenses provided to the CODMs on a regular basis.&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 19.15pt"&gt;&#160;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;All other segment items included in net income or loss are reported on the accompanying unaudited condensed statement of operations and described within their respective disclosures.&lt;/p&gt;</us-gaap:SegmentReportingDisclosureTextBlock>
    <us-gaap:SegmentReportingCodmProfitLossMeasureHowUsedDescription contextRef="cref_598338636" id="ixv-2473">The Company&#x2019;s CODMs have been identified as the Chief Executive Officer and the Chief Financial Officer, who review the operating results for the Company as a whole to make decisions about allocating resources and assessing financial performance.</us-gaap:SegmentReportingCodmProfitLossMeasureHowUsedDescription>
    <us-gaap:NumberOfOperatingSegments
      contextRef="cref_598338636"
      decimals="0"
      id="ixv-4229"
      unitRef="uref_322019321">1</us-gaap:NumberOfOperatingSegments>
    <us-gaap:ScheduleOfSegmentReportingInformationBySegmentTextBlock contextRef="cref_598338636" id="ixv-2479">&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;When evaluating the Company&#x2019;s performance and making key decisions regarding resource allocation the CODMs reviews several key metrics, which include the following:&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"&gt; &lt;tbody&gt;&lt;tr style="vertical-align: bottom"&gt;&lt;td style="white-space: nowrap; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt; &lt;td style="white-space: nowrap; padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt; &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; white-space: nowrap; font-weight: bold; text-align: center"&gt;March 31,&lt;br/&gt; 2026&lt;/td&gt; &lt;td style="white-space: nowrap; padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt; &lt;td style="white-space: nowrap; padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt; &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; white-space: nowrap; font-weight: bold; text-align: center"&gt;December 31,&lt;br/&gt; 2025&lt;/td&gt; &lt;td style="white-space: nowrap; padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;&lt;td style="width: 76%; text-indent: -6.5pt; padding-left: 6.5pt"&gt;Cash&lt;/td&gt; &lt;td style="width: 1%"&gt;&#160;&lt;/td&gt; &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt; &lt;td style="width: 9%; text-align: right"&gt;410,097&lt;/td&gt; &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt; &lt;td style="width: 1%"&gt;&#160;&lt;/td&gt; &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt; &lt;td style="width: 9%; text-align: right"&gt;736,204&lt;/td&gt; &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;&lt;tr style="vertical-align: bottom; background-color: White"&gt;&lt;td style="text-align: left; text-indent: -6.5pt; padding-left: 6.5pt"&gt;Marketable securities and cash held in Trust Account&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left"&gt;$&lt;/td&gt; &lt;td style="text-align: right"&gt;418,094,829&lt;/td&gt; &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left"&gt;$&lt;/td&gt; &lt;td style="text-align: right"&gt;414,549,783&lt;/td&gt; &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;&lt;/tbody&gt;&lt;/table&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 14.55pt"&gt;&#160;&lt;/p&gt;&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"&gt; &lt;tbody&gt;&lt;tr style="vertical-align: bottom"&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt; &lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt; &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;For the&lt;br/&gt; Three&lt;br/&gt;  Months&lt;br/&gt;  Ended&lt;br/&gt; March 31,&lt;br/&gt; 2026&lt;/td&gt; &lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;&lt;td style="width: 88%; text-align: left"&gt;General and administrative costs&lt;/td&gt; &lt;td style="width: 1%"&gt;&#160;&lt;/td&gt; &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt; &lt;td style="width: 9%; text-align: right"&gt;373,673&lt;/td&gt; &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;&lt;tr style="vertical-align: bottom; background-color: White"&gt;&lt;td style="text-align: left"&gt;Interest earned on marketable securities and cash held in Trust Account&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left"&gt;$&lt;/td&gt; &lt;td style="text-align: right"&gt;3,545,046&lt;/td&gt; &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;&lt;/tbody&gt;&lt;/table&gt;</us-gaap:ScheduleOfSegmentReportingInformationBySegmentTextBlock>
    <us-gaap:Cash
      contextRef="cref_886637457"
      decimals="0"
      id="ixv-4230"
      unitRef="uref_1046053354">410097</us-gaap:Cash>
    <us-gaap:Cash
      contextRef="cref_294760605"
      decimals="0"
      id="ixv-4231"
      unitRef="uref_1046053354">736204</us-gaap:Cash>
    <us-gaap:AssetsHeldInTrustNoncurrent
      contextRef="cref_886637457"
      decimals="0"
      id="ixv-4232"
      unitRef="uref_1046053354">418094829</us-gaap:AssetsHeldInTrustNoncurrent>
    <us-gaap:AssetsHeldInTrustNoncurrent
      contextRef="cref_294760605"
      decimals="0"
      id="ixv-4233"
      unitRef="uref_1046053354">414549783</us-gaap:AssetsHeldInTrustNoncurrent>
    <us-gaap:GeneralAndAdministrativeExpense
      contextRef="cref_598338636"
      decimals="0"
      id="ixv-4234"
      unitRef="uref_1046053354">373673</us-gaap:GeneralAndAdministrativeExpense>
    <us-gaap:InvestmentIncomeInterest
      contextRef="cref_598338636"
      decimals="0"
      id="ixv-4235"
      unitRef="uref_1046053354">3545046</us-gaap:InvestmentIncomeInterest>
    <us-gaap:FairValueDisclosuresTextBlock contextRef="cref_598338636" id="ixv-2546">&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;span style="font-weight: bold;"&gt;Note&#160;9 &#x2014;&#160;Fair Value Measurements&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&#160;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;The fair value of the Company&#x2019;s financial assets and liabilities reflects management&#x2019;s estimate of amounts that the Company would have received in connection with the sale of the assets or paid in connection with the transfer of the liabilities in an orderly transaction between market participants at the measurement date. In connection with measuring the fair value of its assets and liabilities, the Company seeks to maximize the use of observable inputs (market data obtained from independent sources) and to minimize the use of unobservable inputs (internal assumptions about how market participants would price assets and liabilities).&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 11.25pt; text-align: justify"&gt;&#160;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;The following fair value hierarchy is used to classify assets and liabilities based on the observable inputs and unobservable inputs used in order to value the assets and liabilities:&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 11.25pt; text-align: justify"&gt;&#160;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in; text-align: justify"&gt;Level&#160;1: Quoted prices in active markets for identical assets or liabilities. An active market for an asset or liability is a market in which transactions for the asset or liability occur with sufficient frequency and volume to provide pricing information on an ongoing basis.&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 11.25pt; text-align: justify"&gt;&#160;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in; text-align: justify"&gt;Level&#160;2: Observable inputs other than Level&#160;1 inputs. Examples of Level&#160;2 inputs include quoted prices in active markets for similar assets or liabilities and quoted prices for identical assets or liabilities in markets that are not active.&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 11.25pt; text-align: justify"&gt;&#160;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in; text-align: justify"&gt;Level&#160;3: Unobservable inputs based on assessment of the assumptions that market participants would use in pricing the asset or liability.&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt; As of March 31, 2026, assets held in the Trust Account were comprised of $676 in cash and $418,017,967 invested in U.S. Treasury Bills. &lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"&gt; &lt;tbody&gt;&lt;tr style="vertical-align: bottom"&gt;&lt;td&gt;&#160;&lt;/td&gt; &lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt; &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;Amortized&lt;br/&gt; Cost&lt;/td&gt; &lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt; &lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt; &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;Unrealized&lt;br/&gt; Loss&lt;/td&gt; &lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt; &lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt; &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;Fair&#160;Value&lt;/td&gt; &lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;&lt;tr style="vertical-align: bottom"&gt;&lt;td style="font-weight: bold"&gt;March 31, 2026&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td colspan="2"&gt;&#160;&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td colspan="2"&gt;&#160;&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td colspan="2"&gt;&#160;&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;/tr&gt;&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;&lt;td style="padding-left: 0.125in; width: 64%; text-align: left"&gt;U.S. Treasury Securities (Mature on 4/14/26 and 6/18/26)&lt;/td&gt; &lt;td style="width: 1%"&gt;&#160;&lt;/td&gt; &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt; &lt;td style="width: 9%; text-align: right"&gt;418,094,153&lt;/td&gt; &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt; &lt;td style="width: 1%"&gt;&#160;&lt;/td&gt; &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt; &lt;td style="width: 9%; text-align: right"&gt;(76,186&lt;/td&gt; &lt;td style="width: 1%; text-align: left"&gt;)&lt;/td&gt; &lt;td style="width: 1%"&gt;&#160;&lt;/td&gt; &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt; &lt;td style="width: 9%; text-align: right"&gt;418,017,967&lt;/td&gt; &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;&lt;/tbody&gt;&lt;/table&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; text-indent: 0.5in; margin: 0pt; text-align: justify"&gt; As of December 31, 2025, assets held in the Trust Account were comprised of $676 in cash and $414,429,619 invested in U.S. Treasury Bills. &lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"&gt; &lt;tbody&gt;&lt;tr style="vertical-align: bottom"&gt;&lt;td&gt;&#160;&lt;/td&gt; &lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt; &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;Amortized&lt;br/&gt; Cost&lt;/td&gt; &lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt; &lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt; &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;Unrealized&lt;br/&gt; Loss&lt;/td&gt; &lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt; &lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt; &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;Fair&#160;Value&lt;/td&gt; &lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;&lt;tr style="vertical-align: bottom"&gt;&lt;td style="font-weight: bold"&gt;December 31, 2025&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td colspan="2"&gt;&#160;&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td colspan="2"&gt;&#160;&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td colspan="2"&gt;&#160;&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;/tr&gt;&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;&lt;td style="padding-left: 0.125in; width: 64%; text-align: left"&gt;U.S. Treasury Securities (Mature on 4/14/26 and 6/18/26)&lt;/td&gt; &lt;td style="width: 1%"&gt;&#160;&lt;/td&gt; &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt; &lt;td style="width: 9%; text-align: right"&gt;414,549,106&lt;/td&gt; &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt; &lt;td style="width: 1%"&gt;&#160;&lt;/td&gt; &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt; &lt;td style="width: 9%; text-align: right"&gt;(119,487&lt;/td&gt; &lt;td style="width: 1%; text-align: left"&gt;)&lt;/td&gt; &lt;td style="width: 1%"&gt;&#160;&lt;/td&gt; &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt; &lt;td style="width: 9%; text-align: right"&gt;414,429,619&lt;/td&gt; &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;&lt;/tbody&gt;&lt;/table&gt;</us-gaap:FairValueDisclosuresTextBlock>
    <us-gaap:FairValueAssetsMeasuredOnRecurringBasisTextBlock contextRef="cref_598338636" id="ixv-2567">&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt; As of March 31, 2026, assets held in the Trust Account were comprised of $676 in cash and $418,017,967 invested in U.S. Treasury Bills. &lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"&gt; &lt;tbody&gt;&lt;tr style="vertical-align: bottom"&gt;&lt;td&gt;&#160;&lt;/td&gt; &lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt; &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;Amortized&lt;br/&gt; Cost&lt;/td&gt; &lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt; &lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt; &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;Unrealized&lt;br/&gt; Loss&lt;/td&gt; &lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt; &lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt; &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;Fair&#160;Value&lt;/td&gt; &lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;&lt;tr style="vertical-align: bottom"&gt;&lt;td style="font-weight: bold"&gt;March 31, 2026&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td colspan="2"&gt;&#160;&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td colspan="2"&gt;&#160;&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td colspan="2"&gt;&#160;&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;/tr&gt;&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;&lt;td style="padding-left: 0.125in; width: 64%; text-align: left"&gt;U.S. Treasury Securities (Mature on 4/14/26 and 6/18/26)&lt;/td&gt; &lt;td style="width: 1%"&gt;&#160;&lt;/td&gt; &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt; &lt;td style="width: 9%; text-align: right"&gt;418,094,153&lt;/td&gt; &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt; &lt;td style="width: 1%"&gt;&#160;&lt;/td&gt; &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt; &lt;td style="width: 9%; text-align: right"&gt;(76,186&lt;/td&gt; &lt;td style="width: 1%; text-align: left"&gt;)&lt;/td&gt; &lt;td style="width: 1%"&gt;&#160;&lt;/td&gt; &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt; &lt;td style="width: 9%; text-align: right"&gt;418,017,967&lt;/td&gt; &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;&lt;/tbody&gt;&lt;/table&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; text-indent: 0.5in; margin: 0pt; text-align: justify"&gt; As of December 31, 2025, assets held in the Trust Account were comprised of $676 in cash and $414,429,619 invested in U.S. Treasury Bills. &lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"&gt; &lt;tbody&gt;&lt;tr style="vertical-align: bottom"&gt;&lt;td&gt;&#160;&lt;/td&gt; &lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt; &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;Amortized&lt;br/&gt; Cost&lt;/td&gt; &lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt; &lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt; &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;Unrealized&lt;br/&gt; Loss&lt;/td&gt; &lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt; &lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt; &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;Fair&#160;Value&lt;/td&gt; &lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;&lt;tr style="vertical-align: bottom"&gt;&lt;td style="font-weight: bold"&gt;December 31, 2025&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td colspan="2"&gt;&#160;&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td colspan="2"&gt;&#160;&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td colspan="2"&gt;&#160;&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;/tr&gt;&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;&lt;td style="padding-left: 0.125in; width: 64%; text-align: left"&gt;U.S. Treasury Securities (Mature on 4/14/26 and 6/18/26)&lt;/td&gt; &lt;td style="width: 1%"&gt;&#160;&lt;/td&gt; &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt; &lt;td style="width: 9%; text-align: right"&gt;414,549,106&lt;/td&gt; &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt; &lt;td style="width: 1%"&gt;&#160;&lt;/td&gt; &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt; &lt;td style="width: 9%; text-align: right"&gt;(119,487&lt;/td&gt; &lt;td style="width: 1%; text-align: left"&gt;)&lt;/td&gt; &lt;td style="width: 1%"&gt;&#160;&lt;/td&gt; &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt; &lt;td style="width: 9%; text-align: right"&gt;414,429,619&lt;/td&gt; &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;&lt;/tbody&gt;&lt;/table&gt;</us-gaap:FairValueAssetsMeasuredOnRecurringBasisTextBlock>
    <us-gaap:Cash
      contextRef="cref_1953307244"
      decimals="0"
      id="ixv-4236"
      unitRef="uref_1046053354">676</us-gaap:Cash>
    <us-gaap:InvestmentOwnedAtFairValue
      contextRef="cref_1953307244"
      decimals="0"
      id="ixv-4237"
      unitRef="uref_1046053354">418017967</us-gaap:InvestmentOwnedAtFairValue>
    <us-gaap:InvestmentMaturityDate contextRef="cref_934243015" id="ixv-4238">2026-04-14</us-gaap:InvestmentMaturityDate>
    <us-gaap:InvestmentMaturityDate contextRef="cref_1340897797" id="ixv-4239">2026-06-18</us-gaap:InvestmentMaturityDate>
    <us-gaap:InvestmentOwnedAtCost
      contextRef="cref_1953307244"
      decimals="0"
      id="ixv-4240"
      unitRef="uref_1046053354">418094153</us-gaap:InvestmentOwnedAtCost>
    <us-gaap:UnrealizedGainLossOnInvestments
      contextRef="cref_1769502998"
      decimals="0"
      id="ixv-4241"
      unitRef="uref_1046053354">-76186</us-gaap:UnrealizedGainLossOnInvestments>
    <us-gaap:InvestmentOwnedAtFairValue
      contextRef="cref_1953307244"
      decimals="0"
      id="ixv-4242"
      unitRef="uref_1046053354">418017967</us-gaap:InvestmentOwnedAtFairValue>
    <us-gaap:Cash
      contextRef="cref_2146114570"
      decimals="0"
      id="ixv-4243"
      unitRef="uref_1046053354">676</us-gaap:Cash>
    <us-gaap:InvestmentOwnedAtFairValue
      contextRef="cref_2146114570"
      decimals="0"
      id="ixv-4244"
      unitRef="uref_1046053354">414429619</us-gaap:InvestmentOwnedAtFairValue>
    <us-gaap:InvestmentMaturityDate contextRef="cref_316440687" id="ixv-4245">2026-04-14</us-gaap:InvestmentMaturityDate>
    <us-gaap:InvestmentMaturityDate contextRef="cref_368141196" id="ixv-4246">2026-06-18</us-gaap:InvestmentMaturityDate>
    <us-gaap:InvestmentOwnedAtCost
      contextRef="cref_2146114570"
      decimals="0"
      id="ixv-4247"
      unitRef="uref_1046053354">414549106</us-gaap:InvestmentOwnedAtCost>
    <us-gaap:UnrealizedGainLossOnInvestments
      contextRef="cref_247669961"
      decimals="0"
      id="ixv-4248"
      unitRef="uref_1046053354">-119487</us-gaap:UnrealizedGainLossOnInvestments>
    <us-gaap:InvestmentOwnedAtFairValue
      contextRef="cref_2146114570"
      decimals="0"
      id="ixv-4249"
      unitRef="uref_1046053354">414429619</us-gaap:InvestmentOwnedAtFairValue>
    <us-gaap:SubsequentEventsTextBlock contextRef="cref_598338636" id="ixv-2654">&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;span style="font-weight: bold;"&gt;Note&#160;10 &#x2014;&#160;Subsequent Events&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;The Company evaluated subsequent events and transactions that occurred after the condensed balance sheet date up to the date that the unaudited condensed financial statements were issued. Based upon this review, other than the below, the Company did not identify any subsequent events that would have required adjustment or disclosure in the unaudited condensed financial statements.&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt; On April 16, 2026, the Company withdrew $1,000,000 from the Trust Account for working capital purposes. &lt;/p&gt;</us-gaap:SubsequentEventsTextBlock>
    <ccxi:WorkingCapitalWithdrawal
      contextRef="cref_1046053354"
      decimals="0"
      id="ixv-4250"
      unitRef="uref_1046053354">1000000</ccxi:WorkingCapitalWithdrawal>
    <ecd:Rule10b51ArrAdoptedFlag contextRef="cref_598338636" id="ixv-4251">false</ecd:Rule10b51ArrAdoptedFlag>
    <ecd:NonRule10b51ArrAdoptedFlag contextRef="cref_598338636" id="ixv-4252">false</ecd:NonRule10b51ArrAdoptedFlag>
    <ecd:Rule10b51ArrTrmntdFlag contextRef="cref_598338636" id="ixv-4253">false</ecd:Rule10b51ArrTrmntdFlag>
    <ecd:NonRule10b51ArrTrmntdFlag contextRef="cref_598338636" id="ixv-4254">false</ecd:NonRule10b51ArrTrmntdFlag>
</xbrl>
